Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	TCF12 IRF2 CHD8 BRD3 IFI16 CASZ1 HOXA4 KANSL3 CSRNP1 KMT2C MRTFB NFATC3 GLI2 GLI3 PITX3 PKD2 ATF1 FGFR1 TAF4B TBX20 PCBP1 PCBP2 OLIG2 THRAP3 NOTCH3 EBF4 MAF	6.08e-06	1390	157	27	GO:0045944
GeneOntologyBiologicalProcess	head development	HSPG2 ABL2 SZT2 ZNF423 CHD8 SPECC1L XRCC1 LHX8 DSCAML1 CSRNP1 MRTFB GLI2 GLI3 PITX3 TMEM108 FGFR1 HERC1 OLIG2 PCDH18 NOTCH3	2.30e-05	919	157	20	GO:0060322
GeneOntologyBiologicalProcess	T cell differentiation in thymus	ABL2 RIPK3 SPN NFATC3 GLI2 GLI3 NKAP	2.69e-05	114	157	7	GO:0033077
GeneOntologyBiologicalProcess	embryonic morphogenesis	HSPG2 ABL2 TRIOBP BRD3 SPECC1L AHDC1 DSCAML1 RYR2 HOXA4 BRD2 GLI2 GLI3 PKD2 FGFR1 TBX20 MAP3K7 HECTD1	3.20e-05	713	157	17	GO:0048598
GeneOntologyBiologicalProcess	neuron development	HSPG2 NYAP2 ABL2 MYCBP2 SZT2 DBNL TRIOBP LHX8 DSCAML1 PDLIM5 KANK1 MRTFB PTPRG HECW2 GLI2 GLI3 RP1L1 PITX3 TMEM108 ATF1 FGFR1 HERC1 OLIG2 CUX1 INPP5J NOTCH3	4.29e-05	1463	157	26	GO:0048666
GeneOntologyBiologicalProcess	central nervous system neuron differentiation	MYCBP2 SZT2 LHX8 GLI2 GLI3 FGFR1 HERC1 TBX20 OLIG2	4.41e-05	217	157	9	GO:0021953
GeneOntologyBiologicalProcess	brain development	HSPG2 ABL2 SZT2 ZNF423 CHD8 XRCC1 LHX8 DSCAML1 MRTFB GLI2 GLI3 PITX3 TMEM108 FGFR1 HERC1 OLIG2 PCDH18 NOTCH3	9.83e-05	859	157	18	GO:0007420
GeneOntologyBiologicalProcess	embryonic organ development	HSPG2 COL27A1 TRIOBP DSCAML1 RYR2 HOXA4 MRTFB GLI2 GLI3 PKD2 FGFR1 TBX20 HECTD1 GAB1	1.02e-04	561	157	14	GO:0048568
GeneOntologyBiologicalProcess	neuron projection development	HSPG2 NYAP2 ABL2 MYCBP2 SZT2 DBNL TRIOBP DSCAML1 PDLIM5 KANK1 MRTFB PTPRG HECW2 GLI2 GLI3 TMEM108 ATF1 FGFR1 HERC1 OLIG2 CUX1 INPP5J NOTCH3	1.13e-04	1285	157	23	GO:0031175
GeneOntologyBiologicalProcess	smoothened signaling pathway involved in ventral spinal cord interneuron specification	GLI2 GLI3	1.72e-04	3	157	2	GO:0021775
GeneOntologyBiologicalProcess	smoothened signaling pathway involved in spinal cord motor neuron cell fate specification	GLI2 GLI3	1.72e-04	3	157	2	GO:0021776
GeneOntologyBiologicalProcess	smoothened signaling pathway involved in ventral spinal cord patterning	GLI2 GLI3	1.72e-04	3	157	2	GO:0021910
GeneOntologyBiologicalProcess	regulation of T cell mediated immunity	RIPK3 SPN ULBP2 RAET1L TNFRSF1B MAP3K7	2.07e-04	111	157	6	GO:0002709
GeneOntologyCellularComponent	chromatin	TCF12 KLF3 IRF2 CHD8 BRD3 XRCC1 LHX8 SRCAP TRRAP CASZ1 HOXA4 KANSL3 CSRNP1 BBX BRD2 ZFHX4 NFATC3 PITX3 BICRAL ATF1 TBX20 MAP3K7 OLIG2 SLX4 CUX1 AFF4 EBF4 MAF	1.90e-05	1480	168	28	GO:0000785
HumanPheno	Abnormal aortic morphology	HSPG2 SPECC1L SRCAP TRRAP CASZ1 GLI2 GLI3 PKD2 FGFR1 NKAP TBX20 MAP3K7 METTL27 SLX4 AFF4 NOTCH3	2.74e-06	401	55	16	HP:0001679
HumanPheno	Abnormal aortic morphology	HSPG2 SPECC1L SRCAP TRRAP CASZ1 GLI2 GLI3 PKD2 FGFR1 NKAP TBX20 MAP3K7 METTL27 AFF4 NOTCH3	3.97e-06	363	55	15	HP:0030963
HumanPheno	Abnormal number of teeth	HSPG2 TCF12 SZT2 COBLL1 SPECC1L SRCAP KMT2C GLI2 GLI3 ARHGAP29 PACS2 FGFR1 MAP3K7 METTL27 CUX1 MAF	5.20e-06	421	55	16	HP:0006483
HumanPheno	Abnormal midface morphology	HSPG2 TCF12 COL27A1 COBLL1 SPECC1L SRCAP CASZ1 KMT2C HECW2 GLI2 PKD2 ARHGAP29 FGFR1 NKAP HERC1 MAP3K7 METTL27 AFF4 NOTCH3 SON MAF	5.47e-06	704	55	21	HP:0000309
HumanPheno	Abnormality of cranial sutures	HSPG2 TCF12 SPECC1L SRCAP AHDC1 CASZ1 GLI3 FGFR1 HERC1 MAP3K7 AFF4 NOTCH3 SON MAF	4.22e-05	388	55	14	HP:0011329
HumanPheno	Midface retrusion	HSPG2 TCF12 COL27A1 CASZ1 KMT2C HECW2 GLI2 PKD2 FGFR1 NKAP SON MAF	4.60e-05	291	55	12	HP:0011800
HumanPheno	Abnormality of the metopic suture	SRCAP GLI3 FGFR1 HERC1 NOTCH3 SON MAF	7.02e-05	97	55	7	HP:0005556
HumanPheno	Abnormal tracheal morphology	TRRAP AHDC1 KMT2C FGFR1 MAP3K7 METTL27 SLX4 AFF4 NOTCH3	7.04e-05	170	55	9	HP:0002778
HumanPheno	Posteriorly rotated ears	HSPG2 ZNF423 CHD8 SRCAP TRRAP CASZ1 GLI2 GLI3 FGFR1 HERC1 MAP3K7 METTL27 AFF4 NOTCH3 MAF	8.82e-05	470	55	15	HP:0000358
HumanPheno	Congenital malformation of the great arteries	HSPG2 SPECC1L SRCAP TRRAP CASZ1 GLI2 GLI3 FGFR1 MAP3K7 METTL27 SLX4 CUX1 AFF4 NOTCH3 SON MAF	9.17e-05	529	55	16	HP:0011603
HumanPheno	Abnormal cranial suture/fontanelle morphology	HSPG2 TCF12 SPECC1L SRCAP AHDC1 CASZ1 GLI2 GLI3 FGFR1 HERC1 MAP3K7 AFF4 NOTCH3 SON MAF	9.26e-05	472	55	15	HP:0000235
HumanPheno	Selective tooth agenesis	TCF12 COBLL1 GLI2 ARHGAP29 FGFR1	1.33e-04	47	55	5	HP:0001592
HumanPheno	Abnormal morphology of the great vessels	HSPG2 SPECC1L SRCAP TRRAP CASZ1 GLI2 GLI3 PKD2 FGFR1 NKAP TBX20 MAP3K7 METTL27 SLX4 CUX1 AFF4 NOTCH3 SON MAF	1.43e-04	736	55	19	HP:0030962
HumanPheno	Rib fusion	HSPG2 CASZ1 GLI3 MAP3K7 SON	1.47e-04	48	55	5	HP:0000902
HumanPheno	Patent ductus arteriosus	HSPG2 SPECC1L TRRAP CASZ1 GLI3 MAP3K7 METTL27 SLX4 CUX1 AFF4 NOTCH3 SON MAF	1.54e-04	382	55	13	HP:0001643
HumanPheno	Abnormality of the palpebral fissures	DOCK3 HSPG2 SZT2 CHD8 SPECC1L SRCAP TRRAP AHDC1 KMT2C GLI3 PACS2 FGFR1 HERC1 MAP3K7 METTL27 SLX4 CUX1 AFF4 NOTCH3 SON MAF	1.72e-04	880	55	21	HP:0008050
HumanPheno	Ptosis	HSPG2 TCF12 SZT2 MARK3 ZNF423 CHD8 SPECC1L AHDC1 ZFHX4 HECW2 GLI2 GLI3 PACS2 FGFR1 MAP3K7 SLX4 AFF4 NOTCH3 MAF	1.99e-04	754	55	19	HP:0000508
HumanPheno	Metopic synostosis	GLI3 FGFR1 HERC1 SON	2.06e-04	28	55	4	HP:0011330
HumanPheno	Dental malocclusion	DOCK3 HSPG2 TCF12 COBLL1 GLI2 ARHGAP29 FGFR1 METTL27	2.31e-04	156	55	8	HP:0000689
HumanPheno	Thoracic aortic aneurysm	HSPG2 SPECC1L CASZ1 PKD2 NKAP METTL27 AFF4	2.83e-04	121	55	7	HP:0012727
HumanPheno	Expressive language delay	SRCAP AHDC1 KMT2C GLI2 HERC1	3.07e-04	56	55	5	HP:0002474
HumanPheno	Language delay	SRCAP AHDC1 KMT2C GLI2 HERC1	3.07e-04	56	55	5	HP:0002336
HumanPheno	Abdominal aortic aneurysm	HSPG2 SPECC1L CASZ1 PKD2 NKAP METTL27 AFF4	3.45e-04	125	55	7	HP:0005112
HumanPheno	Abnormal facial shape	DOCK3 HSPG2 ZNF423 COBLL1 SPECC1L SRCAP ATP10A AHDC1 KMT2C GLI2 PKD2 ARHGAP29 PACS2 FGFR1 NKAP HERC1 TNFRSF1B MAP3K7 METTL27 SLX4 CUX1 AFF4 NOTCH3 SON MAF	3.68e-04	1221	55	25	HP:0001999
HumanPheno	Synostosis of joints	TCF12 COL27A1 GLI3 FGFR1 MAP3K7 METTL27 AFF4 NOTCH3 MAF	3.79e-04	212	55	9	HP:0100240
HumanPheno	Tooth agenesis	TCF12 SZT2 COBLL1 SRCAP GLI2 ARHGAP29 PACS2 FGFR1 MAP3K7 METTL27 CUX1 MAF	3.80e-04	363	55	12	HP:0009804
HumanPheno	Aortic dilatation	HSPG2 SPECC1L CASZ1 PKD2 NKAP METTL27 AFF4 NOTCH3	3.84e-04	168	55	8	HP:0001724
HumanPheno	Aortic aneurysm	HSPG2 SPECC1L CASZ1 PKD2 NKAP METTL27 AFF4 NOTCH3	3.84e-04	168	55	8	HP:0004942
HumanPheno	Atrial septal defect	SZT2 SPECC1L SRCAP TRRAP GLI3 PACS2 FGFR1 NKAP TBX20 MAP3K7 METTL27 SLX4 CUX1 AFF4 SON	4.25e-04	541	55	15	HP:0001631
HumanPheno	Abnormality of the atrial septum	SZT2 SPECC1L SRCAP TRRAP GLI3 PACS2 FGFR1 NKAP TBX20 MAP3K7 METTL27 SLX4 CUX1 AFF4 SON	4.25e-04	541	55	15	HP:0001630
HumanPheno	Abnormal morphology of the radius	COL27A1 SRCAP GLI3 FGFR1 MAP3K7 METTL27 SLX4 AFF4 MAF	4.50e-04	217	55	9	HP:0002818
HumanPheno	Abnormal atrial septum morphology	SZT2 SPECC1L SRCAP TRRAP GLI3 PACS2 FGFR1 NKAP TBX20 MAP3K7 METTL27 SLX4 CUX1 AFF4 SON	4.52e-04	544	55	15	HP:0011994
HumanPheno	Abnormality of the humeroradial joint	COL27A1 SRCAP GLI3 FGFR1 MAP3K7	4.94e-04	62	55	5	HP:0100744
HumanPheno	Downslanted palpebral fissures	DOCK3 SZT2 CHD8 SPECC1L AHDC1 GLI3 PACS2 FGFR1 HERC1 MAP3K7 AFF4 NOTCH3 SON MAF	5.93e-04	497	55	14	HP:0000494
HumanPheno	Oligodontia	SRCAP FGFR1 MAP3K7 CUX1 MAF	6.16e-04	65	55	5	HP:0000677
HumanPheno	Hypoplastic facial bones	HSPG2 COBLL1 SRCAP GLI2 ARHGAP29 FGFR1 HERC1 METTL27 NOTCH3 SON MAF	6.64e-04	331	55	11	HP:0002692
HumanPheno	Aplasia/Hypoplasia of facial bones	HSPG2 COBLL1 SRCAP GLI2 ARHGAP29 FGFR1 HERC1 METTL27 NOTCH3 SON MAF	6.81e-04	332	55	11	HP:0034261
HumanPheno	Agenesis of incisor	COBLL1 GLI2 ARHGAP29 FGFR1	6.84e-04	38	55	4	HP:0006485
HumanPheno	Synostosis involving bones of the upper limbs	TCF12 COL27A1 GLI3 FGFR1 MAP3K7 METTL27 MAF	6.86e-04	140	55	7	HP:0100238
MousePheno	abnormal pupil morphology	UBL7 PPFIA3 GLI3 PITX3 CCDC191 SLX4 MAF	1.85e-05	85	136	7	MP:0001317
MousePheno	abnormal secondary palate morphology	SPECC1L LHX8 CSRNP1 ZFHX4 GLI2 GLI3 ARHGAP29 FGFR1 GAB1	2.48e-05	159	136	9	MP:0013550
MousePheno	abnormal ear development	HSPG2 TRIOBP CACHD1 GLI3 FGFR1 TBX20	3.92e-05	65	136	6	MP:0003938
MousePheno	edema	SZT2 COL27A1 DBNL PTGER4 CASZ1 MRTFB BRD2 NFATC3 GLI2 GLI3 PKD2 TMEM131 TBX20 MAP3K7 PCBP2 AFF4 MAF	4.84e-05	581	136	17	MP:0001785
MousePheno	abnormal palatal shelf elevation	SPECC1L ZFHX4 GLI2 ARHGAP29 FGFR1	1.33e-04	51	136	5	MP:0009885
MousePheno	abnormal fluid regulation	HSPG2 SZT2 ZNF423 COL27A1 DBNL PTGER4 CASZ1 MRTFB BRD2 NFATC3 GLI2 GLI3 PKD2 TMEM131 TBX20 MAP3K7 PCBP2 AFF4 GAB1 MAF	1.41e-04	826	136	20	MP:0001784
MousePheno	abnormal palatal shelf morphology	SPECC1L LHX8 ZFHX4 GLI2 ARHGAP29 FGFR1 GAB1	1.78e-04	121	136	7	MP:0031460
MousePheno	abnormal inner ear development	HSPG2 CACHD1 GLI3	1.86e-04	12	136	3	MP:0011238
MousePheno	abnormal head morphology	HSPG2 KRT13 ZNF423 COL27A1 COBLL1 CHD8 SPECC1L LHX8 AHDC1 CSRNP1 BBX BRD2 ZFHX4 NFATC3 GLI2 GLI3 ARHGAP29 FGFR1 MAP3K7 HECTD1 SLX4 GAB1 SON MAF	1.88e-04	1120	136	24	MP:0000432
MousePheno	abnormal secondary palate development	SPECC1L LHX8 ZFHX4 GLI2 ARHGAP29 FGFR1 GAB1	2.07e-04	124	136	7	MP:0009655
MousePheno	perinatal lethality	HSPG2 MYCBP2 ZNF423 COL27A1 KLF3 CARD10 SPECC1L LHX8 RUNX1T1 PTGER4 AHDC1 KMT2C MRTFB BRD2 ZFHX4 GLI2 GLI3 FGFR1 OLIG2 HECTD1 SLX4 CUX1 AFF4 MAF	2.15e-04	1130	136	24	MP:0002081
MousePheno	cleft secondary palate	SPECC1L LHX8 ZFHX4 GLI2 ARHGAP29 FGFR1 GAB1	2.39e-04	127	136	7	MP:0009890
MousePheno	abnormal eye development	ZNF423 ZBTB4 DBNL ATG14 SPECC1L ZFC3H1 CASZ1 BRD2 GLI3 PITX3 FGD5 TBX20 PCDH18 MAF	2.52e-04	482	136	14	MP:0001286
MousePheno	abnormal palate development	SPECC1L LHX8 ZFHX4 GLI2 ARHGAP29 FGFR1 GAB1	2.64e-04	129	136	7	MP:0009653
MousePheno	increased hair follicle number	PPP2R5A CUX1	2.80e-04	3	136	2	MP:0012110
MousePheno	abnormal craniofacial morphology	HSPG2 KRT13 ZNF423 COL27A1 COBLL1 CACHD1 SPECC1L LHX8 AHDC1 CSRNP1 MRTFB BBX BRD2 ZFHX4 NFATC3 GLI2 GLI3 ARHGAP29 TMEM131 FGFR1 TBX20 MAP3K7 HECTD1 SLX4 AFF4 GAB1 MAF	2.85e-04	1372	136	27	MP:0000428
MousePheno	craniofacial phenotype	HSPG2 KRT13 ZNF423 COL27A1 COBLL1 CACHD1 SPECC1L LHX8 AHDC1 CSRNP1 MRTFB BBX BRD2 ZFHX4 NFATC3 GLI2 GLI3 ARHGAP29 TMEM131 FGFR1 TBX20 MAP3K7 HECTD1 SLX4 AFF4 GAB1 MAF	2.85e-04	1372	136	27	MP:0005382
MousePheno	abnormal palate morphology	HSPG2 COL27A1 SPECC1L LHX8 CSRNP1 ZFHX4 GLI2 GLI3 ARHGAP29 FGFR1 GAB1	2.99e-04	321	136	11	MP:0003755
MousePheno	premature intramembranous bone ossification	AHDC1 GLI3 FGFR1	3.03e-04	14	136	3	MP:0003418
MousePheno	premature cranial suture closure	AHDC1 GLI3 FGFR1	3.03e-04	14	136	3	MP:0000081
MousePheno	premature craniofacial suture closure	AHDC1 GLI3 FGFR1	3.03e-04	14	136	3	MP:0030435
MousePheno	abnormal timing of postnatal eyelid opening	HSPG2 KMT2C GLI3 PITX3 GAB1	3.11e-04	61	136	5	MP:0004874
MousePheno	abnormal sphenoid bone morphology	HSPG2 CSRNP1 BRD2 GLI2 GLI3 FGFR1	3.25e-04	95	136	6	MP:0000104
MousePheno	decreased chondrocyte number	IRS1 ZFHX4 GLI2	3.76e-04	15	136	3	MP:0000167
MousePheno	abnormal osteoblast proliferation	IRS1 FGFR1 NOTCH3	3.76e-04	15	136	3	MP:0030437
MousePheno	perinatal lethality, incomplete penetrance	HSPG2 ZNF423 KLF3 CARD10 SPECC1L LHX8 RUNX1T1 MRTFB BRD2 FGFR1 SLX4 CUX1 AFF4 MAF	3.88e-04	503	136	14	MP:0011090
Domain	DUF1220	NBPF3 NBPF11 NBPF1 NBPF9	6.48e-07	9	161	4	SM01148
Domain	DUF1220	NBPF3 NBPF11 NBPF1 NBPF9	1.67e-06	11	161	4	PF06758
Domain	NBPF_dom	NBPF3 NBPF11 NBPF1 NBPF9	1.67e-06	11	161	4	IPR010630
Domain	NBPF	NBPF3 NBPF11 NBPF1 NBPF9	1.67e-06	11	161	4	PS51316
Domain	SEA	HSPG2 MUC16 MUC12 MUC17	3.45e-05	22	161	4	PF01390
Domain	SEA	HSPG2 MUC16 MUC12 MUC17	4.15e-05	23	161	4	PS50024
Domain	SEA_dom	HSPG2 MUC16 MUC12 MUC17	4.15e-05	23	161	4	IPR000082
Domain	PH	CDC42BPA ARHGAP23 TRIOBP GRB7 IRS1 PLEKHG2 PLEKHG5 FGD5 GAB1 RASAL2	1.53e-04	278	161	10	SM00233
Domain	PH_DOMAIN	CDC42BPA ARHGAP23 TRIOBP GRB7 IRS1 PLEKHG2 PLEKHG5 FGD5 GAB1 RASAL2	1.58e-04	279	161	10	PS50003
Domain	PH_domain	CDC42BPA ARHGAP23 TRIOBP GRB7 IRS1 PLEKHG2 PLEKHG5 FGD5 GAB1 RASAL2	1.62e-04	280	161	10	IPR001849
Domain	SEA	HSPG2 MUC16 MUC17	2.13e-04	14	161	3	SM00200
Domain	BET	BRD3 BRD2	4.38e-04	4	161	2	PF17035
Domain	NET_dom	BRD3 BRD2	4.38e-04	4	161	2	IPR027353
Domain	NET	BRD3 BRD2	4.38e-04	4	161	2	PS51525
Domain	TAFH	RUNX1T1 TAF4B	7.26e-04	5	161	2	SM00549
Domain	TAFH_NHR1	RUNX1T1 TAF4B	7.26e-04	5	161	2	IPR003894
Domain	TAFH	RUNX1T1 TAF4B	7.26e-04	5	161	2	PS51119
Domain	TAFH	RUNX1T1 TAF4B	7.26e-04	5	161	2	PF07531
Pathway	REACTOME_RAC1_GTPASE_CYCLE	DOCK3 ABL2 CDC42BPA CDC42EP4 ARHGAP23 PLEKHG2 ARHGAP29 FGD5 WIPF2	2.08e-05	184	116	9	M41809
Pubmed	A human MAP kinase interactome.	KRT13 ABL2 CDC42BPA CDC42EP4 COBLL1 CHD8 NUP214 MUC12 SPECC1L CCDC88B MKNK1 CEP350 KMT2C TLK1 CSE1L NAV3 BICRAL MAP3K21 MAP3K7 WIPF2 CUX1 WNK2 GAB1	3.66e-16	486	171	23	20936779
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	DOCK3 RNF223 HSPG2 CDC42BPA MYCBP2 SZT2 LONRF1 ZBTB4 CARD10 CHD8 IRS1 NUP214 SRCAP TRRAP ATP13A2 PLEKHG5 AHDC1 CASZ1 NBPF1 KANSL3 ZCCHC14 KMT2C TLK1 BRD2 CCDC34 FGFR1 HERC1 HECTD1 METTL27 CEP170B WNK2	3.86e-15	1105	171	31	35748872
Pubmed	A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.	NBPF3 NBPF8 NBPF12 NBPF11 NBPF1 NBPF9 NBPF10	6.74e-12	21	171	7	16079250
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	TCF12 CDC42EP4 MARK3 DTNB ZNF423 XRCC1 AHDC1 FAF1 TLK1 KANK1 BBX PTPRG GLI2 FGFR1 PCBP2 HECTD1 CUX1 WWC1	1.99e-10	536	171	18	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	TCF12 CDC42EP4 MARK3 DTNB ZNF423 XRCC1 AHDC1 FAF1 TLK1 KANK1 BBX PTPRG GLI2 FGFR1 PCBP2 HECTD1 CUX1 WWC1	2.11e-10	538	171	18	10512203
Pubmed	Human transcription factor protein interaction networks.	HSPG2 TCF12 CDC42BPA MRPL43 KLF3 CHD8 NUP214 XRCC1 LHX8 SRCAP TRRAP EMSY KANSL3 KMT2C RBM12 CSE1L BBX BRD2 ZFHX4 NFATC3 GLI2 GLI3 ATF1 USP54 HERC1 ZNF512 SLX4 CUX1	4.32e-10	1429	171	28	35140242
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DOCK3 ARHGAP23 COL27A1 COBLL1 GRAMD1A ZBTB4 ATG14 ZFC3H1 ATP10A CASZ1 CRY2 CEP350 TLK1 ZNF512 HECTD1 PCDH18 SLX4	4.36e-10	493	171	17	15368895
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	TTLL3 CDC42BPA MYCBP2 MARK3 DTNB TRIOBP TRRAP ATP10A AHDC1 CASZ1 FAF1 NBPF1 KANSL3 KMT2C TLK1 MRTFB PTPRG GLI2 PKD2 ZNF512 HECTD1 THRAP3 CEP170B CUX1 WNK2 AFF4 NOTCH3 MAF	1.08e-09	1489	171	28	28611215
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ABL2 CDC42BPA CDC42EP4 MYCBP2 MARK3 COBLL1 DBNL IRS1 PLEKHG2 CEP350 ZCCHC14 USP31 NFATC3 USP54 MAP3K21 HECTD1 PRRC1 CEP170B GAB1 RASAL2	1.06e-08	861	171	20	36931259
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	NBPF8 NBPF12 MUC16 SPECC1L NBPF11 FAF1 NBPF1 NBPF9 NBPF10 RASAL2	1.37e-08	170	171	10	23314748
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	DOCK3 MYCBP2 LONRF1 ZNF423 ZBTB4 TRIOBP CACHD1 ZFC3H1 DSCAML1 PDLIM5 FAF1 CEP350 BRD2 NAV3 TMEM131 USP54 REPS2 PCBP1 OLIG2 HECTD1 SLX4 CUX1 AFF4 RASAL2	2.18e-08	1285	171	24	35914814
Pubmed	Evolutionary history and genome organization of DUF1220 protein domains.	NBPF8 NBPF12 NBPF1 NBPF9	1.16e-07	10	171	4	22973535
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	CDC42EP4 ARHGAP23 MARK3 COBLL1 DBNL NUP214 PDLIM5 MRTFB ARHGAP29 CRYBG1 PCBP1 PCBP2 WIPF2 GAB1 NOTCH3	1.50e-07	565	171	15	25468996
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	TCF12 ARHGAP23 CHD8 BRD3 PPFIA3 SRCAP TRRAP PPP2R5A BRD2 ZFHX4 GLI3 RTL9 BICRAL NKAP USP54 TAF4B PIP4K2C CEP170B AFF4 WWC1 SON	1.59e-07	1116	171	21	31753913
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	MYCBP2 TRIOBP CHD8 PPFIA3 DSCAML1 ZCCHC14 KMT2C TLK1 MRTFB RBM12	1.91e-07	225	171	10	12168954
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CDC42BPA MYCBP2 DTNB GRAMD1A TRIOBP BRD3 CACHD1 XRCC1 PPFIA3 CEP350 PPP1R3D USP31 PPP2R5A CSE1L BRD2 PTPRG HERC1 ZNF512 MAP3K7 GAB1	2.60e-07	1049	171	20	27880917
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	DOCK3 RIPK3 MYCBP2 ZFC3H1 CCDC88B ATP10A ZFHX4 NKAP MAP3K21 PCBP1 THRAP3 SON	2.62e-07	361	171	12	26167880
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CDC42BPA MARK3 DBNL TRIOBP CHD8 BRD3 SPECC1L ZFC3H1 XRCC1 TRRAP AHDC1 CASZ1 EMSY KMT2C MRTFB BBX BRD2 ULBP2 CRYBG1 ATF1 NKAP CEP170B AFF4 SON	3.62e-07	1497	171	24	31527615
Pubmed	A novel set of nuclear localization signals determine distributions of the alphaCP RNA-binding proteins.	PCBP3 PCBP1 PCBP2	4.65e-07	4	171	3	14612387
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	TCF12 KLF3 IRF2 LHX8 HOXA4 BBX NFATC3 GLI2 GLI3 PITX3 TBX20 OLIG2 CUX1 MAF	5.73e-07	544	171	14	28473536
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	MYCBP2 DBNL CHD8 SPECC1L SRCAP TRRAP EMSY PDLIM5 KMT2C MRTFB PCBP1 PCBP2 THRAP3 CUX1	6.39e-07	549	171	14	38280479
Pubmed	A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth order.	ABL2 EMSY GLI3 TMEM108	9.81e-07	16	171	4	22036096
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	TCF12 CDC42BPA ZNF423 GRAMD1A CHD8 RUNX1T1 MKNK1 BRD2 PCBP1 PCBP2 THRAP3 SON	1.03e-06	411	171	12	35182466
Pubmed	Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin.	PCBP3 PCBP1 PCBP2	1.16e-06	5	171	3	23640898
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	CHD8 XRCC1 IFI16 EMSY MRTFB BBX ZNF512 PCBP1 THRAP3 AFF4	1.55e-06	283	171	10	30585729
Pubmed	Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.	BRD3 FAF1 BRD2 GLI2 GLI3	1.55e-06	40	171	5	28805822
Pubmed	Transcriptional Networks Controlled by NKX2-1 in the Development of Forebrain GABAergic Neurons.	TCF12 LHX8 GLI2 OLIG2 MAF	1.55e-06	40	171	5	27657450
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	NBPF8 NBPF12 ARHGAP23 NBPF11 EMSY NBPF1 SYT15 NBPF9 NBPF10 MAP3K7 PCBP1 PCBP2 HECTD1	1.74e-06	513	171	13	25798074
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	MYCBP2 DSCAML1 CASZ1 GLI2 GLI3 NBPF10 ATF1 FGFR1 THRAP3 NOTCH3 SON	1.80e-06	358	171	11	32460013
Pubmed	Identification of two novel mammalian genes establishes a subfamily of KH-domain RNA-binding proteins.	PCBP3 PCBP1 PCBP2	2.31e-06	6	171	3	10936052
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	UBL7 CHD8 CACHD1 CRY2 GLI3 USP54 HECTD1 THRAP3 SON	2.44e-06	232	171	9	25515538
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	TCF12 ZNF423 KLF3 BRD3 LHX8 SRCAP PDLIM5 ZCCHC14 ZMAT3 BBX BRD2 GLI3 ATF1 TBX20 ZNF512 CUX1	2.72e-06	808	171	16	20412781
Pubmed	A census of human transcription factors: function, expression and evolution.	TCF12 ZBTB4 IRF2 LHX8 HOXA4 BBX ZFHX4 NFATC3 GLI2 GLI3 PITX3 ATF1 TBX20 OLIG2 ZNF541 EBF4 MAF	2.77e-06	908	171	17	19274049
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	ABL2 CDC42BPA ARHGAP23 MARK3 DTNB TRRAP MKNK1 BRD2 FGFR1 NKAP PIP4K2C REPS2 MAP3K21 MAP3K7 PCDH18 THRAP3 AFF4	2.85e-06	910	171	17	36736316
Pubmed	Transforming growth factor β-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling.	RIPK3 TNFRSF1B MAP3K7	4.03e-06	7	171	3	25278099
Pubmed	Secreted metalloproteases ADAMTS9 and ADAMTS20 have a non-canonical role in ciliary vesicle growth during ciliogenesis.	HSPG2 GLI2 GLI3 OLIG2	4.64e-06	23	171	4	30814516
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	BRD3 NUP214 ZFC3H1 XRCC1 SRCAP IFI16 TRRAP AHDC1 CASZ1 EMSY KANSL3 KMT2C BBX BRD2 ATF1 PCBP1 PCBP2 THRAP3 CUX1 SON	6.38e-06	1294	171	20	30804502
Pubmed	Gene regulatory logic for reading the Sonic Hedgehog signaling gradient in the vertebrate neural tube.	GLI2 GLI3 OLIG2	6.42e-06	8	171	3	22265416
Pubmed	A BMP-controlled metabolic/epigenetic signaling cascade directs midfacial morphogenesis.	GLI2 GLI3 FGFR1 TBX20 MAP3K7	6.42e-06	53	171	5	38466355
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TCF12 CDC42BPA CDC42EP4 MUC16 SPECC1L RYR2 CEP350 BBX GLI3 MAP3K7 THRAP3 PRRC1 CUX1 GAB1 RASAL2	7.64e-06	777	171	15	35844135
Pubmed	Suppressor of Fused Is Critical for Maintenance of Neuronal Progenitor Identity during Corticogenesis.	GLI2 GLI3 OLIG2 CUX1	7.75e-06	26	171	4	26387942
Pubmed	Basal Suppression of the Sonic Hedgehog Pathway by the G-Protein-Coupled Receptor Gpr161 Restricts Medulloblastoma Pathogenesis.	GLI2 GLI3 OLIG2 GAB1	9.06e-06	27	171	4	29386106
Pubmed	Neural-specific Sox2 input and differential Gli-binding affinity provide context and positional information in Shh-directed neural patterning.	GLI2 GLI3 OLIG2	9.60e-06	9	171	3	23249739
Pubmed	Context-dependent ciliary regulation of hedgehog pathway repression in tissue morphogenesis.	GLI2 GLI3 OLIG2	9.60e-06	9	171	3	37943875
Pubmed	The loss of Hh responsiveness by a non-ciliary Gli2 variant.	GLI2 GLI3 OLIG2	9.60e-06	9	171	3	25834022
Pubmed	Wnt signaling inhibitors regulate the transcriptional response to morphogenetic Shh-Gli signaling in the neural tube.	GLI2 GLI3 OLIG2	9.60e-06	9	171	3	16950124
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	NYAP2 CDC42BPA SZT2 TRIOBP CHD8 CACHD1 PLEKHG5 KANSL3 KMT2C RBM12 HECW2 WNK2	1.34e-05	529	171	12	14621295
Pubmed	The Shh signalling pathway in early tooth development.	GLI2 GLI3 FGFR1	1.37e-05	10	171	3	10512189
Pubmed	The kinesin protein Kif7 is a critical regulator of Gli transcription factors in mammalian hedgehog signaling.	GLI2 GLI3 OLIG2	1.37e-05	10	171	3	19549984
Pubmed	Gli3 acts as a repressor downstream of Ihh in regulating two distinct steps of chondrocyte differentiation.	GLI2 GLI3 FGFR1	1.37e-05	10	171	3	16284117
Pubmed	Gli3 utilizes Hand2 to synergistically regulate tissue-specific transcriptional networks.	GLI2 GLI3 MAF	1.37e-05	10	171	3	33006313
Pubmed	Suppressor of Fused Chaperones Gli Proteins To Generate Transcriptional Responses to Sonic Hedgehog Signaling.	GLI2 GLI3 OLIG2	1.37e-05	10	171	3	27849569
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	TRRAP CASZ1 KMT2C RBM12 CSE1L PCBP1 THRAP3 SON	1.43e-05	220	171	8	35785414
Pubmed	The DNA sequence and biological annotation of human chromosome 1.	ABL2 CDC42BPA SZT2 NBPF11 IFI16 ATP13A2 CASZ1 MKNK1 CEP350 PPP2R5A HMCN1 NBPF10 OR6K3 TNFRSF1B MAP3K21 THRAP3 RASAL2	1.45e-05	1031	171	17	16710414
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	PCBP3 MYCBP2 DBNL TRIOBP SPECC1L ZFC3H1 PDLIM5 CEP350 TMEM131 ZNF512 PCBP1 PCBP2 THRAP3 SON	1.53e-05	724	171	14	36232890
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	PCBP3 MRPL43 TRIOBP C11orf24 NUP214 CRY2 CEP350 KANSL3 TLK1 KANK1 PPP2R5A NKAP PCBP1 PCBP2 THRAP3 SLX4 PRRC1 CEP170B	1.71e-05	1155	171	18	20360068
Pubmed	A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development.	RIPK3 TNFRSF1B MAP3K7	1.87e-05	11	171	3	28898696
Pubmed	Distinct Activities of Gli1 and Gli2 in the Absence of Ift88 and the Primary Cilia.	GLI2 GLI3 OLIG2	1.87e-05	11	171	3	30791390
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	PCBP3 CHD8 NUP214 XRCC1 EMSY BBX BRD2 ATF1 ZNF512 PCBP1 PCBP2 THRAP3 SLX4 CUX1 AFF4 SON	2.14e-05	954	171	16	36373674
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ABL2 DBNL PLEKHG2 EMSY PDLIM5 CEP350 MRTFB NFATC3 ARHGAP29 TMEM131 NKAP USP54 PCBP1 PCBP2 CEP170B	2.27e-05	853	171	15	28718761
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	CHD8 BRD3 NUP214 TRRAP AHDC1 ZMAT3 KMT2C CSE1L BRD2 RTL9 CRYBG1	2.28e-05	469	171	11	27634302
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NYAP2 MYCBP2 TRIOBP CHD8 SPECC1L PPFIA3 EMSY NFATC3 PIP4K2C PCBP1 THRAP3 CEP170B CUX1 WNK2 AFF4 RASAL2	2.39e-05	963	171	16	28671696
Pubmed	Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains.	PCBP1 PCBP2	2.40e-05	2	171	2	7607214
Pubmed	αCP Poly(C) binding proteins act as global regulators of alternative polyadenylation.	PCBP1 PCBP2	2.40e-05	2	171	2	23629627
Pubmed	Influenza virus infection activates TAK1 to suppress RIPK3-independent apoptosis and RIPK1-dependent necroptosis.	RIPK3 MAP3K7	2.40e-05	2	171	2	39044278
Pubmed	Distinct poly(rC) binding protein KH domain determinants for poliovirus translation initiation and viral RNA replication.	PCBP1 PCBP2	2.40e-05	2	171	2	12414943
Pubmed	Splicing factor poly(rC)-binding protein 1 is a novel and distinctive tumor suppressor.	PCBP1 PCBP2	2.40e-05	2	171	2	30132844
Pubmed	A novel protein-processing domain in Gli2 and Gli3 differentially blocks complete protein degradation by the proteasome.	GLI2 GLI3	2.40e-05	2	171	2	17283082
Pubmed	New mouse models of congenital anorectal malformations.	GLI2 GLI3	2.40e-05	2	171	2	10693670
Pubmed	The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription.	BRD3 BRD2	2.40e-05	2	171	2	18406326
Pubmed	Regulation of ryanodine receptor-dependent calcium signaling by polycystin-2.	RYR2 PKD2	2.40e-05	2	171	2	17404231
Pubmed	Identification of two KH domain proteins in the alpha-globin mRNP stability complex.	PCBP1 PCBP2	2.40e-05	2	171	2	7556077
Pubmed	The acute myeloid leukemia fusion protein AML1-ETO targets E proteins via a paired amphipathic helix-like TBP-associated factor homology domain.	TCF12 RUNX1T1	2.40e-05	2	171	2	16803958
Pubmed	Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo.	GLI2 GLI3	2.40e-05	2	171	2	29967343
Pubmed	Kinetics of hedgehog-dependent full-length Gli3 accumulation in primary cilia and subsequent degradation.	GLI2 GLI3	2.40e-05	2	171	2	20154143
Pubmed	αCP binding to a cytosine-rich subset of polypyrimidine tracts drives a novel pathway of cassette exon splicing in the mammalian transcriptome.	PCBP1 PCBP2	2.40e-05	2	171	2	26896798
Pubmed	Aberrantly activated TAK1 links neuroinflammation and neuronal loss in Alzheimer's disease mouse models.	RIPK3 MAP3K7	2.40e-05	2	171	2	36912451
Pubmed	Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers.	NBPF11 NBPF1	2.40e-05	2	171	2	7700633
Pubmed	Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity.	TCF12 RUNX1T1	2.40e-05	2	171	2	19204326
Pubmed	Poly(rC) binding protein 2 binds to stem-loop IV of the poliovirus RNA 5' noncoding region: identification by automated liquid chromatography-tandem mass spectrometry.	PCBP1 PCBP2	2.40e-05	2	171	2	8855318
Pubmed	Normal exon copy number of the GLI2 and GLI3 genes in patients with esophageal atresia.	GLI2 GLI3	2.40e-05	2	171	2	23442119
Pubmed	Chromosomal localization, gene structure and transcription pattern of the ORFX gene, a homologue of the MHC-linked RING3 gene.	BRD3 BRD2	2.40e-05	2	171	2	9373153
Pubmed	Multivalent binding of the ETO corepressor to E proteins facilitates dual repression controls targeting chromatin and the basal transcription machinery.	TCF12 RUNX1T1	2.40e-05	2	171	2	19289505
Pubmed	A set of highly conserved RNA-binding proteins, alphaCP-1 and alphaCP-2, implicated in mRNA stabilization, are coexpressed from an intronless gene and its intron-containing paralog.	PCBP1 PCBP2	2.40e-05	2	171	2	10455157
Pubmed	The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).	FGFR1 CUX1	2.40e-05	2	171	2	21330321
Pubmed	Notch signaling modulates MUC16 biosynthesis in an in vitro model of human corneal and conjunctival epithelial cell differentiation.	MUC16 NOTCH3	2.40e-05	2	171	2	21508102
Pubmed	Adult Gli2+/-;Gli3Δ699/+ Male and Female Mice Display a Spectrum of Genital Malformation.	GLI2 GLI3	2.40e-05	2	171	2	27814383
Pubmed	FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway.	GLI2 FGFR1	2.40e-05	2	171	2	26936993
Pubmed	Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGFR) 1 Activity and Influences Sensitivity to FGFR Kinase Inhibitors.	PTPRG FGFR1	2.40e-05	2	171	2	29371290
Pubmed	Antagonistic effects of cellular poly(C) binding proteins on vesicular stomatitis virus gene expression.	PCBP1 PCBP2	2.40e-05	2	171	2	21752917
Pubmed	PCBP1 and PCBP2 both bind heavily oxidized RNA but cause opposing outcomes, suppressing or increasing apoptosis under oxidative conditions.	PCBP1 PCBP2	2.40e-05	2	171	2	32647012
Pubmed	A study on etiology of incontinence in double knockout mouse model.	GLI2 GLI3	2.40e-05	2	171	2	36272934
Pubmed	IFT25 links the signal-dependent movement of Hedgehog components to intraflagellar transport.	GLI2 GLI3 OLIG2	2.49e-05	12	171	3	22595669
Pubmed	Dual function of suppressor of fused in Hh pathway activation and mouse spinal cord patterning.	GLI2 GLI3 OLIG2	2.49e-05	12	171	3	22182519
Pubmed	Spop regulates Gli3 activity and Shh signaling in dorsoventral patterning of the mouse spinal cord.	GLI2 GLI3 OLIG2	2.49e-05	12	171	3	28412462
Pubmed	The novel ciliogenesis regulator DYRK2 governs Hedgehog signaling during mouse embryogenesis.	GLI2 GLI3 OLIG2	2.49e-05	12	171	3	32758357
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	MYCBP2 BRD3 NUP214 IFI16 TRRAP EMSY KANSL3 TLK1 BRD2 PACS2 NKAP PCBP1 THRAP3 SON	3.17e-05	774	171	14	15302935
Pubmed	T396I mutation of mouse Sufu reduces the stability and activity of Gli3 repressor.	GLI2 GLI3 OLIG2	3.22e-05	13	171	3	25760946
Pubmed	Chd8 Mutation Leads to Autistic-like Behaviors and Impaired Striatal Circuits.	CHD8 OLIG2 CUX1	3.22e-05	13	171	3	28402856
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TCF12 MYCBP2 CHD8 XRCC1 IFI16 TRRAP AHDC1 EMSY KANSL3 KMT2C TLK1 RBM12 BICRAL ATF1 PCBP2 THRAP3 CUX1	3.40e-05	1103	171	17	34189442
Interaction	YWHAG interactions	ABL2 CDC42BPA ARHGAP23 MYCBP2 MARK3 COBLL1 DBNL IRS1 SPECC1L PLEKHG2 IFI16 TRRAP PLEKHG5 FAF1 CEP350 PPP1R3D USP31 KANK1 CSE1L NFATC3 ARHGAP29 PACS2 NKAP USP54 MAP3K21 HECTD1 THRAP3 PRRC1 CEP170B GAB1 RASAL2 WWC1 SON	4.54e-09	1248	171	33	int:YWHAG
Interaction	YWHAH interactions	ABL2 CDC42BPA CDC42EP4 MYCBP2 MARK3 COBLL1 DBNL IRS1 SPECC1L PLEKHG2 PLEKHG5 FAF1 CEP350 PPP1R3D ZCCHC14 USP31 KANK1 NFATC3 PACS2 USP54 HERC1 MAP3K21 MAP3K7 HECTD1 PRRC1 CEP170B WNK2 GAB1 RASAL2 WWC1	1.34e-08	1102	171	30	int:YWHAH
Interaction	AR interactions	ABL2 CDC42BPA MYCBP2 GRB7 CHD8 BRD3 SRCAP IFI16 TRRAP AHDC1 CASZ1 EMSY KANSL3 KMT2C RBM12 CSE1L BRD2 GLI2 GLI3 USP54 REPS2 PCBP1 PCBP2 THRAP3 CUX1 AFF4 SON	7.92e-08	992	171	27	int:AR
Interaction	YWHAB interactions	ABL2 CDC42BPA ARHGAP23 MYCBP2 MARK3 COBLL1 IRS1 TRRAP PLEKHG5 PDLIM5 CEP350 PPP1R3D USP31 KANK1 NFATC3 PACS2 FGFR1 USP54 PIP4K2C MAP3K21 HECTD1 CEP170B GAB1 RASAL2 WWC1 SON	4.48e-07	1014	171	26	int:YWHAB
Interaction	FBXW11 interactions	UBL7 TRIOBP CHD8 IRS1 CACHD1 IFI16 PLEKHG5 FAF1 CRY2 GLI2 GLI3 USP54 MAP3K7 HECTD1 THRAP3 WWC1 SON	6.10e-07	473	171	17	int:FBXW11
Interaction	YWHAQ interactions	ABL2 CDC42BPA ARHGAP23 MYCBP2 MARK3 COBLL1 IRS1 SPECC1L IFI16 PLEKHG5 CRY2 CEP350 PPP1R3D USP31 KANK1 CSE1L NFATC3 PACS2 FGD5 USP54 MAP3K21 PCBP1 HECTD1 CEP170B GAB1 RASAL2 WWC1	8.42e-07	1118	171	27	int:YWHAQ
Interaction	TOP3B interactions	DOCK3 RNF223 HSPG2 CDC42BPA MYCBP2 SZT2 LONRF1 ZBTB4 CARD10 CHD8 IRS1 NUP214 SRCAP TRRAP ATP13A2 PLEKHG5 AHDC1 CASZ1 NBPF1 KANSL3 ZCCHC14 KMT2C TLK1 BRD2 CCDC34 FGFR1 HERC1 HECTD1 METTL27 CEP170B WNK2	2.10e-06	1470	171	31	int:TOP3B
Interaction	NUP43 interactions	PCBP3 SZT2 DBNL CHD8 NUP214 ZFC3H1 SRCAP IFI16 AHDC1 EMSY RYR2 KANSL3 MRTFB BBX NKAP ZNF512 SLX4 SON	6.46e-06	625	171	18	int:NUP43
Interaction	SFN interactions	ABL2 CDC42BPA MYCBP2 MARK3 LONRF1 COBLL1 GRB7 IRS1 CEP350 PPP1R3D USP31 NFATC3 PACS2 USP54 MAP3K21 HECTD1 CEP170B GAB1 RASAL2	6.98e-06	692	171	19	int:SFN
Interaction	CDH1 interactions	CDC42EP4 ARHGAP23 MARK3 COBLL1 DBNL IRS1 NUP214 PDLIM5 MRTFB CSE1L PTPRG ARHGAP29 CRYBG1 FGFR1 PCBP1 PCBP2 HECTD1 WIPF2 GAB1 NOTCH3	8.61e-06	768	171	20	int:CDH1
Interaction	CSNK2A2 interactions	GRAMD1A BRD3 IRS1 ZFC3H1 XRCC1 IFI16 TRRAP EMSY RBM12 BRD2 GLI3 ARHGAP29 ATF1 NKAP PIP4K2C REPS2 PCBP1 PCDH18 THRAP3	1.17e-05	718	171	19	int:CSNK2A2
Interaction	ARHGEF2 interactions	CDC42BPA MYCBP2 MARK3 DBNL PDLIM5 TLK1 PPP2R5A FGFR1 HECTD1 SLX4 CEP170B	1.24e-05	256	171	11	int:ARHGEF2
Interaction	YWHAE interactions	ABL2 CDC42BPA MYCBP2 MARK3 COBLL1 DBNL IRS1 PLEKHG5 FAF1 CRY2 PPP1R3D USP31 TLK1 KANK1 PACS2 FGD5 USP54 MAP3K21 MAP3K7 PCBP1 HECTD1 CEP170B WNK2 GAB1 RASAL2 WWC1	2.16e-05	1256	171	26	int:YWHAE
Interaction	PRPF3 interactions	CARD10 BRD3 IFI16 TRRAP BRD2 NKAP PCBP1 HECTD1 THRAP3 SLX4 SON	4.03e-05	291	171	11	int:PRPF3
Interaction	GSK3A interactions	MARK3 AHDC1 CEP350 KANK1 GLI3 ARHGAP29 CRYBG1 HECTD1 THRAP3 SLX4 CEP170B GAB1 RASAL2 WWC1	4.37e-05	464	171	14	int:GSK3A
Interaction	ATOH1 interactions	TCF12 MYCBP2 RUNX1T1 TRRAP CEP350 SON	6.11e-05	80	171	6	int:ATOH1
Interaction	FOXP1 interactions	KLF3 XRCC1 EMSY ZFHX4 PKD2 HERC1 TNFRSF1B PCBP2 PCSK4 CUX1	6.91e-05	256	171	10	int:FOXP1
Interaction	LIG3 interactions	KLF3 IRF2 BRD3 XRCC1 IFI16 TRRAP BRD2 TNFRSF1B HECTD1	7.09e-05	207	171	9	int:LIG3
Interaction	SGF29 interactions	KRT13 TCF12 DTNB KLF3 TRRAP KANSL3 MAP3K7 HECTD1	8.10e-05	164	171	8	int:SGF29
Interaction	DIRAS3 interactions	CDC42BPA MARK3 ATG14 CACHD1 PTPRG HERC1 MAP3K21 HECTD1 GAB1 RASAL2	8.37e-05	262	171	10	int:DIRAS3
Cytoband	1q21.1	NBPF8 NBPF11 NBPF9 NBPF10	8.76e-05	62	171	4	1q21.1
GeneFamily	Neuroblastoma breakpoint family	NBPF3 NBPF8 NBPF12 NBPF11 NBPF1 NBPF9 NBPF10	6.14e-11	23	111	7	662
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ARHGAP23 TRIOBP GRB7 IRS1 PLEKHG2 PLEKHG5 FGD5 GAB1 RASAL2	5.03e-06	206	111	9	682
GeneFamily	CD molecules\|Mucins	MUC16 MUC12 MUC17	2.76e-04	21	111	3	648
Coexpression	MARTINEZ_RESPONSE_TO_TRABECTEDIN	TCF12 IRS1 KANK1 PTPRG CRYBG1 TMEM131 HERC1 CUX1	1.13e-09	50	170	8	M5077
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	TCF12 CDC42BPA MYCBP2 MARK3 IRS1 SPECC1L TRRAP AHDC1 PDLIM5 CEP350 TLK1 PPP2R5A CSE1L BBX NFATC3 PKD2 NAV3 ARHGAP29 TMEM131 BICRAL CUX1 WWC1 SON	8.61e-09	856	170	23	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	TCF12 CDC42BPA MYCBP2 MARK3 IRS1 SPECC1L TRRAP CEP350 TLK1 BBX PKD2 ARHGAP29 TMEM131 CUX1 WWC1	4.20e-07	466	170	15	M13522
Coexpression	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN	CDC42EP4 ZBTB4 IRS1 CACHD1 PTGER4 PDLIM5 CSRNP1 KANK1 MRTFB BBX PTPRG BICRAL USP54 HERC1 PCBP2 HECTD1 AFF4 WWC1 MAF	1.36e-06	807	170	19	M16651
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	IRS1 ZFC3H1 AHDC1 CEP350 ZCCHC14 TLK1 KANK1 BBX NAV3 BICRAL WWC1	4.53e-06	300	170	11	M8702
Coexpression	GSE40655_FOXO1_KO_VS_WT_NTREG_UP	MYCBP2 SZT2 ZBTB4 IRS1 ZFC3H1 KMT2C PPP2R5A BBX OLIG2	6.70e-06	200	170	9	M9439
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL	RIPK3 TTLL3 TMC7 RUNX1T1 KANSL3 CSRNP1 HMCN1 CRYBG1 TNFRSF1B METTL27	1.87e-05	286	170	10	M45746
Coexpression	SCHLOSSER_SERUM_RESPONSE_UP	CHD8 CEP350 BRD2 FGFR1 MAP3K7 WIPF2 GAB1	1.88e-05	126	170	7	M16381
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	TCF12 PDLIM5 FAF1 KANK1 PTPRG CUX1 RASAL2 WWC1	2.05e-05	176	170	8	M39223
Coexpression	HAY_BONE_MARROW_STROMAL	HSPG2 FAM114A1 CDC42EP4 ZNF423 IRS1 CACHD1 RUNX1T1 ZFHX4 PTPRG GLI2 GLI3 NAV3 TMEM108 FGFR1 PCDH18 NOTCH3	4.23e-05	767	170	16	M39209
Coexpression	GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP	FAM114A1 ZFC3H1 SRCAP PDLIM5 GLI3 USP54 REPS2 MAF	4.92e-05	199	170	8	M8115
Coexpression	GSE24142_DN2_VS_DN3_THYMOCYTE_DN	TCF12 MARK3 CARD10 MKNK1 ZMAT3 PPP2R5A TMEM131 NOTCH3	4.92e-05	199	170	8	M4558
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	HSPG2 SZT2 C11orf24 CHD8 TRRAP ATP13A2 WIPF2 AFF4	4.92e-05	199	170	8	M7254
Coexpression	HALLMARK_MITOTIC_SPINDLE	CDC42BPA CDC42EP4 PLEKHG2 PDLIM5 TLK1 PKD2 ARHGAP29 RASAL2	4.92e-05	199	170	8	M5893
Coexpression	GSE40273_XBP1_KO_VS_WT_TREG_DN	SPN MYCBP2 CCDC88B TRRAP CEP350 ZMAT3 TMEM131 HERC1	4.92e-05	199	170	8	M9124
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	TCF12 ABL2 NUP214 RUNX1T1 ATF1 FGFR1 OLIG2 THRAP3 AFF4 MAF	5.24e-05	323	170	10	M9150
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	COL27A1 CARD10 PTGER4 ATP10A CASZ1 PDLIM5 SLC9A2 KANK1 HMCN1 GLI2 GLI3 PITX3 ARHGAP29 TMEM108 MAP3K21 OLIG2 GAB1 EBF4 MAF	7.40e-05	1074	170	19	M1941
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	SPN MYCBP2 MARK3 GRAMD1A ZBTB4 ZFC3H1 IFI16 CCDC88B PTGER4 CEP350 ZMAT3 KMT2C TLK1 RBM12 BBX NFATC3 CRYBG1 HERC1 TNFRSF1B PCBP1 THRAP3 SON MAF	1.02e-04	1492	170	23	M40023
Coexpression	SHEN_SMARCA2_TARGETS_UP	ZFC3H1 CEP350 PPP1R3D TLK1 KANK1 MRTFB CSE1L ARHGAP29 TMEM131 ATF1 SON	1.20e-04	429	170	11	M29
Coexpression	LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	KRT13 BRD3 IFI16 RBM12 BBX MAP3K7	1.35e-04	120	170	6	M2250
Coexpression	CUI_TCF21_TARGETS_2_DN	TMC7 ZBTB4 KLF3 CARD10 IRS1 IFI16 PTGER4 ATP10A KMT2C KANK1 BBX PTPRG HECW2 ARHGAP29 FGD5 SON	1.47e-04	854	170	16	M1533
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000	LHX8 RUNX1T1 IFI16 HMCN1 ZFHX4 PTPRG PKD2 PCDH18	2.28e-05	147	168	8	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	NUP214 CACHD1 LHX8 RUNX1T1 IFI16 CEP350 ZCCHC14 USP31 HMCN1 ZFHX4 PTPRG GLI2 GLI3 NAV3 CRYBG1 FGFR1 PCDH18 CUX1	4.03e-05	769	168	18	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000	NUP214 CEP350 ZCCHC14 USP31 PTPRG GLI3 NAV3 FGFR1 CUX1	4.47e-05	209	168	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000	ABL2 DTNB CHD8 SRCAP PDLIM5 FAF1 RYR2 KMT2C BBX HMCN1 NFATC3 CSNK1G1 ARHGAP29 TAF4B HERC1 RASAL2 ZNF541 MAF	4.53e-05	776	168	18	gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200	NUP214 IFI16 RYR2 CEP350 USP31 ZFHX4 TBX20 CUX1	5.43e-05	166	168	8	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	MYCBP2 NUP214 RYR2 CEP350 ZCCHC14 USP31 BBX GLI3 TBX20 MAP3K7 CUX1 SON	5.94e-05	385	168	12	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	ANKRD42 ABL2 DTNB CHD8 LHX8 SRCAP RYR2 KMT2C BBX BRD2 HMCN1 PKD2 ARHGAP29 TAF4B HERC1 RASAL2 ZNF541 MAF	6.18e-05	795	168	18	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_100	IFI16 RYR2 USP31 ZFHX4 TBX20 CUX1	6.25e-05	86	168	6	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500	NUP214 ZCCHC14 USP31 PTPRG GLI3 CUX1	7.58e-05	89	168	6	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2	FAM114A1 TCF12 CDC42BPA CDC42EP4 SZT2 COL27A1 MRPL43 TRIOBP C11orf24 CACHD1 RUNX1T1 ATP10A PDLIM5 HMCN1 PTPRG HECW2 GLI2 GLI3 PKD2 NAV3 FGFR1 PCSK4 PCDH18	8.30e-05	1208	168	23	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000	UBL7 ABL2 CHD8 BRD3 RUNX1T1 AHDC1 DSCAML1 FAF1 ZCCHC14 BBX BRD2 CSNK1G1 FGFR1 TAF4B PCDH18 RASAL2 SON MAF	9.01e-05	819	168	18	gudmap_developingGonad_e16.5_testes_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000	TMC7 RUNX1T1 IFI16 PDLIM5 RYR2 USP31 RBM12 ZFHX4 HECW2 GLI3 PKD2 TBX20 MAP3K7 PCDH18 PRRC1 CUX1 SON MAF	1.00e-04	826	168	18	DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000	UBL7 TCF12 CHD8 BRD3 RUNX1T1 PDLIM5 FAF1 HOXA4 TLK1 BRD2 ZFHX4 PTPRG TMEM108 FGFR1 PCDH18 CUX1 RASAL2 SON	1.31e-04	844	168	18	gudmap_developingGonad_e11.5_testes and mesonephros_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	ANKRD42 ABL2 CHD8 LHX8 RUNX1T1 SRCAP RYR2 KMT2C BBX BRD2 HMCN1 ARHGAP29 TAF4B HERC1 RASAL2 ZNF541 MAF	1.53e-04	778	168	17	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_500	LHX8 RUNX1T1 IFI16 ZFHX4 PCDH18	1.90e-04	67	168	5	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500	MUC16 IRS1 RUNX1T1 RYR2 HMCN1 GLI2 GLI3 ARHGAP29 TMEM108 REPS2 PCDH18	1.92e-04	372	168	11	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200	NUP214 RYR2 CEP350 USP31 CUX1	2.18e-04	69	168	5	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000	UBL7 BRD3 RUNX1T1 AHDC1 FAF1 BRD2 FGFR1 PCDH18 RASAL2 SON MAF	2.20e-04	378	168	11	gudmap_developingGonad_e16.5_testes_1000_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	MYCBP2 SZT2 KLF3 NUP214 LHX8 RUNX1T1 IFI16 CEP350 USP31 HMCN1 ZFHX4 PTPRG GLI2 GLI3 MAP3K7 PCDH18 CUX1	2.32e-04	806	168	17	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#3_top-relative-expression-ranked_100	LHX8 RUNX1T1 ZFHX4	2.53e-04	16	168	3	gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	MYCBP2 ZNF423 NUP214 RUNX1T1 IFI16 RYR2 CEP350 ZCCHC14 USP31 BBX ZFHX4 PTPRG GLI3 TBX20 MAP3K7 CUX1 SON	2.75e-04	818	168	17	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_100	IFI16 ZFHX4 CUX1	3.05e-04	17	168	3	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_100_k5
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000	MYCBP2 PDLIM5 RYR2 CEP350 USP31 PTPRG TBX20 MAP3K7 PRRC1 CUX1	3.09e-04	330	168	10	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	UBL7 MUC16 IRS1 CACHD1 RUNX1T1 PTGER4 CEP350 MRTFB HMCN1 ZFHX4 PTPRG GLI2 CCDC34 GLI3 ARHGAP29 FGFR1 PCDH18	3.12e-04	827	168	17	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000	UBL7 TCF12 BRD3 RUNX1T1 PDLIM5 FAF1 PTPRG TMEM108 FGFR1 PCDH18 CUX1 RASAL2 SON	3.34e-04	533	168	13	gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000	UBL7 ABL2 CHD8 BRD3 RUNX1T1 AHDC1 FAF1 HOXA4 BRD2 ZFHX4 PTPRG FGFR1 PCDH18 CUX1 RASAL2 SON MAF	3.89e-04	843	168	17	gudmap_developingGonad_e11.5_testes_1000
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ABL2 MYCBP2 ZMAT3 MRTFB HMCN1 ZFHX4 PTPRG NFATC3 NAV3	4.14e-08	184	171	9	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ZNF423 CACHD1 RUNX1T1 HECW2 NAV3 CD300LG FGD5 RASAL2	5.97e-08	192	171	9	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ZNF423 CACHD1 RUNX1T1 HECW2 NAV3 CD300LG FGD5 RASAL2	6.24e-08	193	171	9	52e918884877b6659cdca0496390e440f73694a9
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF423 CACHD1 MRTFB HMCN1 PTPRG HECW2 ARHGAP29 FGD5 RASAL2	6.52e-08	194	171	9	0b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HSPG2 CDC42BPA ZNF423 RUNX1T1 MRTFB PTPRG NAV3 ARHGAP29 FGD5	6.81e-08	195	171	9	023e3c97dd3696d74f002ff8da0c04d876c82aef
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ZNF423 RUNX1T1 PTPRG HECW2 NAV3 CD300LG FGD5 RASAL2	7.12e-08	196	171	9	023312af38f816a44b407e0daa32590d953caf99
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	COL27A1 RUNX1T1 RYR2 HMCN1 PTPRG GLI2 GLI3 NAV3 TMEM108	7.44e-08	197	171	9	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ARHGAP23 ZNF423 RUNX1T1 PTPRG HECW2 NAV3 FGD5 RASAL2	7.44e-08	197	171	9	cd509e49bbdbf991cc5913960ff3ef275ad40628
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ARHGAP23 ZNF423 RUNX1T1 PTPRG HECW2 NAV3 FGD5 RASAL2	7.44e-08	197	171	9	412cb5f37df57121ddd1492021445479c7cbccbf
ToppCell	390C-Endothelial_cells-Endothelial-E-\|390C / Donor, Lineage, Cell class and subclass (all cells)	TMC7 CARD10 PLEKHG5 HECW2 ARHGAP29 CD300LG TMEM108 FGD5	4.55e-07	178	171	8	804ac3725c1f88e2212172bfb9aa01d97a735621
ToppCell	390C-Endothelial_cells-Endothelial-E\|390C / Donor, Lineage, Cell class and subclass (all cells)	TMC7 CARD10 PLEKHG5 HECW2 ARHGAP29 CD300LG TMEM108 FGD5	4.55e-07	178	171	8	ad6dc4a375664c919bd48c35c48a561fc5a7de8c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ZNF423 CACHD1 SYT15 HECW2 NAV3 FGD5 RASAL2	4.75e-07	179	171	8	8f9e538c822940785130297712b75131812a4603
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DOCK3 ATP10A RYR2 SLC9A2 ZFHX4 PTPRG FGFR1 RASAL2	4.75e-07	179	171	8	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 PLEKHG5 HOXA4 HECW2 CD300LG FGD5 INPP5J RASAL2	5.16e-07	181	171	8	a53f05c4c47465ee62e353716456bd09ab464b23
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDC42EP4 ZNF423 PDLIM5 KANK1 ZFHX4 GLI2 GLI3 NBPF10	6.61e-07	187	171	8	5d3d68519c8e19f10c29f9d81712125be78ca15a
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDC42EP4 ZNF423 PDLIM5 KANK1 ZFHX4 GLI2 GLI3 NBPF10	6.61e-07	187	171	8	5c73010fe4c85fb5cc1273f5504821229ca0cc4b
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDC42EP4 ZNF423 PDLIM5 KANK1 ZFHX4 GLI2 GLI3 NBPF10	6.61e-07	187	171	8	93c78fc7f126132eb84feb47be2c4e8c568b9e91
ToppCell	COVID-19-lung-Vein_EC\|lung / Disease (COVID-19 only), tissue and cell type	HSPG2 ZNF423 CACHD1 RUNX1T1 MRTFB HECW2 ARHGAP29 FGD5	6.88e-07	188	171	8	d582b76fc2faac526c9bf97503041129e1a6a211
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDC42EP4 ZNF423 CACHD1 KANK1 ZFHX4 GLI2 GLI3 NBPF10	7.45e-07	190	171	8	3a55cc5dc2549788bfe55f649686887b21a1fdd2
ToppCell	COVID-19-lung-Vein_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HSPG2 ZNF423 CACHD1 RUNX1T1 MRTFB HECW2 ARHGAP29 FGD5	7.45e-07	190	171	8	1caeaef78326734c1e31a0c4739190d5c5a77b9e
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CDC42BPA USP31 PPP2R5A MRTFB HECW2 ARHGAP29 FGD5 RASAL2	7.45e-07	190	171	8	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDC42EP4 ZNF423 CACHD1 KANK1 ZFHX4 GLI2 GLI3 NBPF10	7.45e-07	190	171	8	1c3d601422efa60fad8565f9ccd9032b847e4a91
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HSPG2 CDC42BPA ZNF423 RUNX1T1 MRTFB PTPRG ARHGAP29 FGD5	7.75e-07	191	171	8	50601ef0a5a8f2c2120922989e08e85bf2d9b4ab
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RUNX1T1 RYR2 HMCN1 PTPRG GLI2 PKD2 NAV3 TMEM108	7.75e-07	191	171	8	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYNDIG1 IRS1 RUNX1T1 HMCN1 ZFHX4 GLI2 GLI3 NAV3	8.06e-07	192	171	8	67e845e513e76e820f55e2f0d15eb16f2944d05c
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RUNX1T1 RYR2 HMCN1 PTPRG GLI2 PKD2 NAV3 TMEM108	8.06e-07	192	171	8	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Gen_Cap\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF423 CACHD1 PPP2R5A MRTFB HMCN1 HECW2 ARHGAP29 FGD5	8.38e-07	193	171	8	6e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF423 CACHD1 PPP2R5A MRTFB HECW2 ARHGAP29 FGD5 RASAL2	8.38e-07	193	171	8	af5108260783e69a7d67896c5bf64f862525926d
ToppCell	Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ARHGAP23 GRAMD1A PLEKHG2 IFI16 USP31 HECW2 RP1L1 ARHGAP29	8.38e-07	193	171	8	ad2df9b77999780860141be6ec366afc0172a331
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10\|TCGA-Colorectal / Sample_Type by Project: Shred V9	SYNDIG1 ATP10A HMCN1 TNFRSF8 GLI2 GLI3 FGD5 FGFR1	8.38e-07	193	171	8	194e7fa00a50cc4e026987b715323d125d79594e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 RUNX1T1 PTPRG HECW2 NAV3 CD300LG FGD5 RASAL2	8.72e-07	194	171	8	e55dc30e200c9f576804acb642175eb4fa9146b5
ToppCell	10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 CARD10 HMCN1 PTPRG ARHGAP29 CD300LG FGD5 FGFR1	9.06e-07	195	171	8	22a481927147ec4ae9d59e6af7c87df0e9cb51e4
ToppCell	facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 ARHGAP23 CARD10 HMCN1 CD300LG FGD5 RASAL2 MAF	9.06e-07	195	171	8	12ba6d95e42d06b1991b011043c0e3370a7b4131
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	HSPG2 RUNX1T1 HECW2 ARHGAP29 FGD5 FGFR1 HERC1 RASAL2	9.42e-07	196	171	8	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 PCBP3 ZNF423 RUNX1T1 HECW2 NAV3 FGD5 RASAL2	9.42e-07	196	171	8	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	nucseq-Endothelial-Endothelial_Vascular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CDC42BPA ZNF423 RUNX1T1 MRTFB PTPRG HECW2 ARHGAP29 FGD5	9.42e-07	196	171	8	686533fd3fba8e4df96b9dd1307e870e89db4332
ToppCell	nucseq-Mesenchymal-Fibroblastic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RUNX1T1 RYR2 HMCN1 PTPRG GLI2 PKD2 NAV3 TMEM108	9.42e-07	196	171	8	7d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ZNF423 RUNX1T1 PTPRG HECW2 NAV3 FGD5 RASAL2	1.02e-06	198	171	8	07701c73137947ed4a27e225975329235bbb8734
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ZNF423 RUNX1T1 PTPRG HECW2 NAV3 FGD5 RASAL2	1.02e-06	198	171	8	31ba87552be97c9b78c9e82f98e96699ccb19824
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	COL27A1 RUNX1T1 RYR2 HMCN1 PTPRG GLI2 GLI3 NAV3	1.02e-06	198	171	8	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ZNF423 RUNX1T1 PTPRG HECW2 NAV3 FGD5 RASAL2	1.02e-06	198	171	8	fa84bf8533d1b91d2c2bcf06b710670605072b89
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	HSPG2 FAM114A1 CDC42BPA RUNX1T1 ZFHX4 PTPRG GLI3 FGFR1	1.06e-06	199	171	8	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	IFI16 PLEKHG5 KMT2C MRTFB HMCN1 PTPRG ARHGAP29 SON	1.10e-06	200	171	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RUNX1T1 RYR2 HMCN1 PTPRG GLI2 PKD2 NAV3 FGFR1	1.10e-06	200	171	8	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	Control-B_intermediate-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TEPSIN NBPF12 NBPF11 NBPF1 NBPF10 BICRAL CCDC191	1.44e-06	144	171	7	984470ff6ddce4c743e2db78fa98dae055aaa273
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HSPG2 RIPK3 ZNF423 PPFIA3 RUNX1T1 NAV3 ARHGAP29	2.56e-06	157	171	7	275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CARD10 RUNX1T1 MRTFB HECW2 NAV3 ARHGAP29 CD300LG	3.28e-06	163	171	7	977a970b1296234c22178420294cea73506ee02f
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_C\|TCGA-Thymus / Sample_Type by Project: Shred V9	GRB7 MUC16 DSCAML1 PITX3 FGD5 MAP3K21 INPP5J	3.28e-06	163	171	7	2dac87d15051151ccf193760ddd8b82534c3f922
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CARD10 RUNX1T1 MRTFB HECW2 NAV3 ARHGAP29 CD300LG	3.28e-06	163	171	7	ba7d02db0f0e2f9916ec8db52c067c87b6917c23
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	SZT2 BBX NFATC3 MAP3K21 CCDC191 THRAP3 SON	3.70e-06	166	171	7	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	Endothelial-B-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	CARD10 RYR2 ZFHX4 PITX3 ARHGAP29 CD300LG MAF	3.85e-06	167	171	7	6a03d16165e0b003092c39972928981abd4a75aa
ToppCell	Control-B_intermediate-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	TEPSIN NBPF12 NBPF11 NBPF1 NBPF10 BICRAL CCDC191	3.85e-06	167	171	7	948504367ecf58144d9dd74d2ec531358fc4b309
ToppCell	ASK428-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	FAM114A1 CDC42BPA COBLL1 GRB7 MUC16 ARHGAP29 USP54	5.23e-06	175	171	7	e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231\|Adult / Lineage, Cell type, age group and donor	ZNF423 CARD10 RUNX1T1 DSCAML1 ZFHX4 HECW2 FGD5	5.85e-06	178	171	7	c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GRAMD1A RGS9 PLEKHG2 USP31 HECW2 ARHGAP29 FGD5	6.30e-06	180	171	7	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	PND07-28-samps-Endothelial-Postnatal_endothelial-capillary_endothelial_Hpgd-CA4_high\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PCBP3 CARD10 RGS9 CASZ1 ARHGAP29 FGD5 RASAL2	6.53e-06	181	171	7	9cd5e5c285c2b628db9d59709af053defd7c0aff
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KRT13 TMC7 ARHGAP23 USP31 NAV3 CRYBG1 WNK2	6.77e-06	182	171	7	678eadd57e7e830fc2bf9fd35616d3badce01705
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KRT13 TMC7 ARHGAP23 USP31 NAV3 CRYBG1 WNK2	6.77e-06	182	171	7	8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 PCBP3 ZNF423 RUNX1T1 HECW2 NAV3 FGD5	7.27e-06	184	171	7	688428103e8b19f45f2f65d70a0f30c904c8411c
ToppCell	3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HSPG2 HECW2 RP1L1 ARHGAP29 CD300LG FGD5 RASAL2	7.53e-06	185	171	7	a987dbf6adf533c5f8a0a8a465a6c8e67e0ffcc8
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	SYNDIG1 RUNX1T1 GLI2 GLI3 NAV3 TMEM108 NOTCH3	7.80e-06	186	171	7	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DSCAML1 PTPRG GLI3 ARHGAP29 FGFR1 REPS2 WWC1	7.80e-06	186	171	7	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDC42EP4 PDLIM5 KANK1 ZFHX4 GLI2 GLI3 NBPF10	8.08e-06	187	171	7	dd1d91f101b837bba513f77defa6e6902b2c0570
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDC42EP4 PDLIM5 KANK1 ZFHX4 GLI2 GLI3 NBPF10	8.08e-06	187	171	7	4d2115a05ec36dd179ca1d4a525f2d4501aea557
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDC42EP4 PDLIM5 KANK1 ZFHX4 GLI2 GLI3 NBPF10	8.08e-06	187	171	7	ae90c263f80c36a410150d499e268d198944a3d9
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 RUNX1T1 SYT15 HECW2 NAV3 FGD5 RASAL2	8.08e-06	187	171	7	35c382c0aabd46906113e5db30ea24bb8e658899
ToppCell	COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	HSPG2 ZNF423 RUNX1T1 MRTFB PTPRG ARHGAP29 FGD5	8.08e-06	187	171	7	2d20193a6cacdfa4877457c97b0077408942186c
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DSCAML1 PTPRG GLI3 ARHGAP29 FGFR1 REPS2 WWC1	8.08e-06	187	171	7	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL27A1 RUNX1T1 RYR2 HMCN1 PTPRG NAV3 TMEM108	8.08e-06	187	171	7	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	Endothelial-endothelial_cell_of_artery\|World / Lineage, Cell type, age group and donor	HSPG2 ZNF423 RUNX1T1 HMCN1 PTPRG ARHGAP29 FGD5	8.66e-06	189	171	7	fdd89c71113ac99b7c800c6def8888e512ff1128
ToppCell	IPF-Epithelial-Basal\|Epithelial / Disease state, Lineage and Cell class	ARHGAP23 DTNB CACHD1 FAF1 USP31 KANK1 PTPRG	8.96e-06	190	171	7	4f15842b424eefadbfe451875e517cf70e29607f
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDC42EP4 ZNF423 KANK1 ZFHX4 GLI2 GLI3 NBPF10	8.96e-06	190	171	7	5c64b727669b23d2a23c8ad1d5d6caab7af37d56
ToppCell	Control-Endothelial-VE_Capillary_B\|Endothelial / Disease state, Lineage and Cell class	CDC42EP4 CASZ1 MRTFB PTPRG HECW2 CD300LG TMEM108	8.96e-06	190	171	7	7f3f419fffe02934b6f27b697f7a6401072491ed
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HSPG2 CDC42BPA ZNF423 RUNX1T1 HMCN1 PTPRG ARHGAP29	8.96e-06	190	171	7	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDC42EP4 ZNF423 CACHD1 KANK1 ZFHX4 GLI2 GLI3	8.96e-06	190	171	7	b56c55f608b30f7379941ac7d5f0f5200f305fca
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG2 RUNX1T1 ATP10A GLI2 GLI3 RASAL2 NOTCH3	9.27e-06	191	171	7	7b0d42a877540dbb346a76a62403e0d5d3e07fa6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLEKHG2 RUNX1T1 ATP10A GLI2 GLI3 RASAL2 NOTCH3	9.27e-06	191	171	7	cd854b9c426924fdc84bf7f411f6dea447143e79
ToppCell	10x3'2.3-week_14-16-Endothelial-stroma-immature_EC\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HSPG2 CARD10 SYNDIG1 ARHGAP29 CD300LG FGD5 MAF	9.59e-06	192	171	7	5af3b2b38495e925497c48f605d618bbf970965d
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDC42EP4 ZNF423 KANK1 ZFHX4 GLI2 GLI3 NBPF10	9.59e-06	192	171	7	f7e4509003d71f805b9d4587098e90d2897b6739
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 TMC7 ARHGAP23 RUNX1T1 IFI16 FGD5 TNFRSF1B	9.59e-06	192	171	7	56b021c297a21dff357531f21e2464f85186106d
ToppCell	primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CDC42EP4 ZNF423 KANK1 ZFHX4 GLI2 GLI3 NBPF10	9.59e-06	192	171	7	705ce805cb00a53793b57bcf466d0fbec590a83c
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HSPG2 COBLL1 ATP10A MRTFB HMCN1 ARHGAP29 FGD5	9.92e-06	193	171	7	3f8280ef849d95b2fcea5e6824b95a07febc96d0
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF423 PPP2R5A MRTFB HMCN1 HECW2 NAV3 FGD5	9.92e-06	193	171	7	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RUNX1T1 RYR2 HMCN1 PTPRG GLI2 NAV3 TMEM108	9.92e-06	193	171	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	SYNDIG1 RUNX1T1 RYR2 HMCN1 PTPRG GLI3 NAV3	9.92e-06	193	171	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	IPF-Endothelial-VE_Venous\|IPF / Disease state, Lineage and Cell class	HSPG2 ZNF423 RUNX1T1 MRTFB PTPRG NAV3 ARHGAP29	9.92e-06	193	171	7	29a655fa80feaabe846c90a28363b037e22d24ae
ToppCell	IPF-Endothelial-VE_Venous\|World / Disease state, Lineage and Cell class	HSPG2 ZNF423 RUNX1T1 MRTFB PTPRG NAV3 ARHGAP29	9.92e-06	193	171	7	ef66a46e7ab44fcc4005a23416e6da478a4cce37
ToppCell	facs-Thymus-nan-3m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF12 ATP10A KMT2C PPP2R5A RBM12 NFATC3 CUX1	1.03e-05	194	171	7	f1661f9f2439fca5c1012c693b0744c4e3b90a9b
ToppCell	PCW_13-14-Endothelial-Endothelial_mature-endo_capillary_(2)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	LONRF1 COBLL1 CARD10 USP31 ARHGAP29 ULBP2 CRYBG1	1.03e-05	194	171	7	3c31ac44e8cf4eca3ba7b8bfc05ad3e96a970956
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	SYNDIG1 RUNX1T1 RYR2 HMCN1 GLI2 GLI3 NAV3	1.03e-05	194	171	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATP13A2 HMCN1 PTPRG HECW2 ARHGAP29 FGD5 RASAL2	1.03e-05	194	171	7	f159ef8541d75a4e98468947f231bb463bec922c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 CACHD1 SYT15 HECW2 NAV3 FGD5 RASAL2	1.03e-05	194	171	7	74a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell	facs-Thymus-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TCF12 ATP10A KMT2C PPP2R5A RBM12 NFATC3 CUX1	1.03e-05	194	171	7	cda1b197efb199330ea7ab25a7cee22cae22589d
ToppCell	LPS_only-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF423 CACHD1 USP31 MRTFB HECW2 ARHGAP29 FGD5	1.03e-05	194	171	7	58f069efdefa0366033764446b9d6ffd4a17807e
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ZNF423 CACHD1 USP31 MRTFB HECW2 ARHGAP29 FGD5	1.03e-05	194	171	7	bfd92ec75facb0ba55c31e5f2e089d983b3d0169
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	RUNX1T1 RYR2 ZFHX4 GLI3 TMEM108 PCDH18 MAF	1.03e-05	194	171	7	85e00861c5068a27d0cf0ae677f420c8245baa9a
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	HSPG2 ZNF423 RUNX1T1 HECW2 NAV3 FGD5 RASAL2	1.03e-05	194	171	7	a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ZNF423 RUNX1T1 ZFHX4 PTPRG GLI2 GLI3 TMEM108	1.06e-05	195	171	7	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	ARHGAP23 COL27A1 CACHD1 IFI16 PLEKHG5 GLI3 FGFR1	1.06e-05	195	171	7	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	(1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells\|World / Stress and Cell class	ARHGAP23 HMCN1 ARHGAP29 CD300LG FGD5 RASAL2 MAF	1.06e-05	195	171	7	6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a
Drug	Sotalol hydrochloride [959-24-0]; Down 200; 13uM; MCF7; HT_HG-U133A	CDC42BPA SPN SZT2 GRB7 KLF3 AHDC1 EMSY NFATC3 TAF4B WIPF2	2.62e-06	199	170	10	7338_DN
Drug	Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HT_HG-U133A	DTNB GRB7 C11orf24 IFI16 ATP10A RYR2 TLK1 NFATC3 NOTCH3	1.73e-05	196	170	9	4591_UP
Drug	Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; PC3; HT_HG-U133A	CDC42BPA KLF3 PPFIA3 ZCCHC14 GLI2 FGFR1 PCBP2 NOTCH3 MAF	1.73e-05	196	170	9	4100_DN
Drug	Prostaglandin E1; Down 200; 10uM; PC3; HT_HG-U133A	SPN TRIOBP PPFIA3 AHDC1 CEP350 TNFRSF8 NAV3 FGFR1 NOTCH3	1.73e-05	196	170	9	6571_DN
Drug	Suxibuzone [27470-51-5]; Down 200; 9.2uM; MCF7; HT_HG-U133A	ABL2 GRB7 EMSY RYR2 ZCCHC14 CSE1L TAF4B INPP5J GAB1	1.73e-05	196	170	9	6065_DN
Drug	Pesticides	NBPF8 NBPF12 IRS1 XRCC1 NBPF11 NBPF1 NBPF9 NBPF10	1.75e-05	150	170	8	ctd:D010575
Drug	Monocrotaline [315-22-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	SPN COBLL1 GRB7 PPFIA3 SRCAP EMSY PDLIM5 BICRAL FGFR1	1.80e-05	197	170	9	6771_DN
Drug	Neostigmine bromide [114-80-7]; Up 200; 13.2uM; HL60; HT_HG-U133A	ABL2 TMC7 KLF3 SRCAP ZFHX4 OLIG2 CEP170B RASAL2 WWC1	1.87e-05	198	170	9	2432_UP
Drug	Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; HL60; HT_HG-U133A	SYNDIG1 PTGER4 CRY2 GLI3 FGFR1 OLIG2 CEP170B INPP5J AFF4	1.87e-05	198	170	9	2725_UP
Drug	Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; HL60; HT_HG-U133A	TMC7 SPN DTNB ZFHX4 GLI2 FGFR1 REPS2 CEP170B INPP5J	1.87e-05	198	170	9	2424_UP
Drug	Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	SPN NUP214 RUNX1T1 EMSY RYR2 ZCCHC14 TLK1 SLC9A2 FGFR1	1.95e-05	199	170	9	3978_DN
Drug	Melphalan	IRF2 RUNX1T1 PDLIM5 PPP2R5A MRTFB ZFHX4 PTPRG HECW2 GLI3 GAB1	4.51e-05	276	170	10	ctd:D008558
Drug	PCB 66	RYR2 PCBP1 PCBP2	6.46e-05	11	170	3	CID000036185
Drug	Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A	SZT2 ZNF423 SRCAP RYR2 CEP350 TLK1 INPP5J RASAL2	7.51e-05	184	170	8	3244_UP
Drug	2-Chloropyrazine [14508-49-7]; Down 200; 35uM; MCF7; HT_HG-U133A	TRIOBP ATP13A2 RYR2 NFATC3 TAF4B CEP170B RASAL2 NOTCH3	1.09e-04	194	170	8	3570_DN
Drug	CGX 0596987; Down 200; 20uM; PC3; HT_HG-U133A	COBLL1 NUP214 XRCC1 PPFIA3 SRCAP PDLIM5 CRY2 PPP1R3D	1.09e-04	194	170	8	6417_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	COBLL1 SRCAP RYR2 TLK1 CSE1L INPP5J RASAL2 NOTCH3	1.13e-04	195	170	8	2283_DN
Drug	Clebopride maleate [84370-95-6]; Up 200; 8.2uM; HL60; HT_HG-U133A	CDC42BPA SPN DTNB SRCAP IFI16 ATP13A2 AHDC1 CSE1L	1.13e-04	195	170	8	1292_UP
Drug	2-butenal	NBPF3 NBPF11 RUNX1T1 PTGER4 USP31 MRTFB ZFHX4 GLI2	1.13e-04	195	170	8	ctd:C012796
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A	HSPG2 CDC42EP4 SPN IFI16 ATP13A2 CRY2 FGFR1 WIPF2	1.17e-04	196	170	8	1323_UP
Drug	Acetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A	SZT2 COBLL1 PDLIM5 RYR2 CEP350 PPP1R3D FGFR1 RASAL2	1.17e-04	196	170	8	1686_UP
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A	SPN KLF3 AHDC1 KANSL3 SLC9A2 TAF4B NOTCH3 MAF	1.17e-04	196	170	8	4208_DN
Drug	Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	SZT2 TRIOBP CASZ1 RYR2 SLC9A2 RBM12 WIPF2 NOTCH3	1.17e-04	196	170	8	7356_DN
Drug	Chlorambucil [305-03-3]; Up 200; 13.2uM; PC3; HT_HG-U133A	DOCK3 SPN NFATC3 GLI2 SIGLEC6 FGFR1 TAF4B MAF	1.17e-04	196	170	8	4523_UP
Drug	PF-00539745-00 [351321-33-0]; Down 200; 10uM; MCF7; HT_HG-U133A	PCBP3 ZNF423 SYNDIG1 IFI16 ZCCHC14 NFATC3 TNFRSF8 GAB1	1.17e-04	196	170	8	5974_DN
Drug	Epitiostanol [2363-58-8]; Down 200; 13uM; PC3; HT_HG-U133A	ABL2 CDC42BPA SPN NUP214 RYR2 KANSL3 NOTCH3 MAF	1.17e-04	196	170	8	4204_DN
Drug	Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A	SPN TRIOBP C11orf24 SRCAP ATP13A2 NFATC3 FGFR1 REPS2	1.21e-04	197	170	8	1909_UP
Drug	Acetylsalicylsalicylic acid [530-75-6]; Up 200; 13.4uM; PC3; HT_HG-U133A	SPN DTNB KLF3 PDLIM5 PPP1R3D SLC9A2 GLI2 FGFR1	1.21e-04	197	170	8	2061_UP
Drug	Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A	TMC7 NUP214 SRCAP AHDC1 CEP350 NFATC3 GLI3 FGFR1	1.21e-04	197	170	8	6792_DN
Drug	Epitiostanol [2363-58-8]; Down 200; 13uM; MCF7; HT_HG-U133A	SPN SZT2 COBLL1 PPFIA3 AHDC1 RYR2 CRYBG1 NOTCH3	1.21e-04	197	170	8	7342_DN
Drug	Glimepiride [93479-97-1]; Up 200; 8.2uM; HL60; HT_HG-U133A	CDC42BPA TMC7 COBLL1 CASZ1 MRTFB REPS2 AFF4 WWC1	1.25e-04	198	170	8	2154_UP
Drug	Glipizide [29094-61-9]; Down 200; 9uM; MCF7; HT_HG-U133A	COBLL1 CHD8 SRCAP TLK1 PPP2R5A CSE1L NFATC3 BICRAL	1.25e-04	198	170	8	4991_DN
Drug	Deltaline [6836-11-9]; Up 200; 7.8uM; MCF7; HT_HG-U133A	HSPG2 PCBP3 DTNB NUP214 SRCAP SLC9A2 TNFRSF8 TNFRSF1B	1.25e-04	198	170	8	3831_UP
Drug	Pridinol methanesulfonate salt [6856-31-1]; Up 200; 10.2uM; HL60; HT_HG-U133A	CDC42BPA SYNDIG1 CASZ1 CRY2 GLI3 FGFR1 OLIG2 INPP5J	1.25e-04	198	170	8	2715_UP
Drug	Hecogenin [467-55-0]; Up 200; 9.2uM; HL60; HT_HG-U133A	CARD10 SYNDIG1 PDLIM5 CRY2 GLI3 FGFR1 OLIG2 AFF4	1.25e-04	198	170	8	2716_UP
Drug	Caffeic acid [3331-39-5]; Up 200; 22.2uM; HL60; HT_HG-U133A	CDC42BPA CDC42EP4 TMC7 ATP13A2 TLK1 ZFHX4 REPS2 CEP170B	1.25e-04	198	170	8	3053_UP
Drug	Flucytosine [2022-85-7]; Up 200; 31uM; HL60; HT_HG-U133A	ABL2 CDC42BPA SZT2 COBLL1 ATP10A PDLIM5 ZFHX4 AFF4	1.29e-04	199	170	8	3073_UP
Drug	Cyproheptadine hydrochloride [969-33-5]; Up 200; 12.4uM; HL60; HG-U133A	CDC42BPA CDC42EP4 SPN GRB7 KLF3 PPFIA3 SRCAP TRRAP	1.29e-04	199	170	8	2021_UP
Drug	Bacampicillin hydrochloride [37661-08-8]; Up 200; 8uM; PC3; HT_HG-U133A	DOCK3 SPN NUP214 RUNX1T1 PDLIM5 TNFRSF1B AFF4 MAF	1.29e-04	199	170	8	4592_UP
Drug	Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; HL60; HT_HG-U133A	HSPG2 COBLL1 RUNX1T1 SRCAP INPP5J AFF4 WWC1 NOTCH3	1.29e-04	199	170	8	3113_UP
Drug	Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; PC3; HT_HG-U133A	CDC42BPA IRF2 C11orf24 BRD3 RYR2 CEP350 FGFR1 PCBP2	1.29e-04	199	170	8	5879_DN
Drug	5149715; Up 200; 10uM; MCF7; HT_HG-U133A_EA	KRT13 CDC42BPA MYCBP2 RGS9 CASZ1 TLK1 TAF4B INPP5J	1.29e-04	199	170	8	890_UP
Drug	Vitexin [3681-93-4]; Down 200; 9.2uM; MCF7; HT_HG-U133A	HSPG2 SPN SZT2 TRIOBP NFATC3 BICRAL FGFR1 NOTCH3	1.34e-04	200	170	8	4413_DN
Drug	Tobramycin [32986-56-4]; Up 200; 8.6uM; HL60; HT_HG-U133A	ABL2 KLF3 SYNDIG1 ATP13A2 ATP10A TNFRSF8 FGFR1 AFF4	1.34e-04	200	170	8	2481_UP
Disease	seasonal allergic rhinitis	ABL2 EMSY GLI3 TMEM108	2.93e-05	32	164	4	EFO_0003956
Disease	level of UL16-binding protein 6 in blood serum	ULBP2 RAET1L	3.07e-05	2	164	2	OBA_2043185
Disease	body mass index, type 2 diabetes mellitus	NYAP2 COBLL1 FAF1	8.95e-05	16	164	3	EFO_0004340, MONDO_0005148
Disease	cortical thickness	GDF5-AS1 HSPG2 NYAP2 MYCBP2 MARK3 ZNF423 TRIOBP RUNX1T1 ATP13A2 FAF1 GLI3 NAV3 TMEM108 TMEM131 FGFR1 MAP3K7 WNK2	1.64e-04	1113	164	17	EFO_0004840
Disease	cholesteryl esters to total lipids in medium HDL percentage	NYAP2 COBLL1 NFATC3 CD300LG	2.70e-04	56	164	4	EFO_0022251
Disease	hippocampal volume	MYCBP2 ZNF423 IRF2 DSCAML1 RYR2 GLI3 WNK2 WWC1	2.70e-04	297	164	8	EFO_0005035
Disease	QRS duration	NYAP2 TCF12 ZBTB4 PDLIM5 FAF1 HMCN1 TBX20 MAP3K7	2.76e-04	298	164	8	EFO_0005055
Disease	eosinophil percentage of leukocytes	UBL7 DOCK3 KLF3 ATG14 BRD3 EMSY KANSL3 TNFRSF8 TMEM131 TNFRSF1B OLIG2 CUX1 MAF	2.89e-04	746	164	13	EFO_0007991
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	RNF223 NYAP2 COBLL1 CD300LG	3.30e-04	59	164	4	EFO_0022260
Disease	hypertension	NYAP2 SZT2 ZNF423 CASZ1 MKNK1 FGD5 TBX20 PCDH18	3.37e-04	307	164	8	EFO_0000537
Disease	Malignant neoplasm of breast	GRB7 NUP214 EMSY HOXA4 ZCCHC14 SLC9A2 ARHGAP29 FGD5 FGFR1 USP54 REPS2 CUX1 GAB1 RASAL2 NOTCH3 ZNF541	3.39e-04	1074	164	16	C0006142
Disease	Heart valve disease	RIPK3 SPN FGFR1	3.99e-04	26	164	3	C0018824
Disease	total lipids in chylomicrons and extremely large VLDL measurement	RNF223 NYAP2 COBLL1 CD300LG	3.99e-04	62	164	4	EFO_0022306
Disease	brain connectivity measurement	GDF5-AS1 TRIOBP KLF3 FAF1 GLI3 NAV3 ATF1 MAP3K7 WNK2	4.23e-04	400	164	9	EFO_0005210
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	RNF223 NYAP2 COBLL1 CD300LG	4.24e-04	63	164	4	EFO_0022292
Disease	blood phosphate measurement	NBPF3 HSPG2 BBX TMEM131 CUX1 MAF	4.41e-04	174	164	6	EFO_0010972
Disease	body fat percentage, fasting blood insulin measurement	NYAP2 COBLL1	4.54e-04	6	164	2	EFO_0004466, EFO_0007800
Disease	renal system measurement, uric acid measurement	PKD2 MAF	4.54e-04	6	164	2	EFO_0004742, EFO_0004761
Disease	PR interval	HSPG2 MYCBP2 MARK3 PDLIM5 FAF1 RYR2 FGFR1 TBX20 WIPF2 THRAP3	4.75e-04	495	164	10	EFO_0004462
Disease	keratinocyte carcinoma	CCDC88B KANK1 ULBP2 RAET1L CUX1	5.26e-04	118	164	5	EFO_0010176
Disease	congenital heart disease (implicated_via_orthology)	CHD8 KMT2C TBX20 SON	6.00e-04	69	164	4	DOID:1682 (implicated_via_orthology)
Disease	Craniosynostosis syndrome	TCF12 FGFR1	6.33e-04	7	164	2	cv:C0010278
Disease	brain measurement, neuroimaging measurement	GDF5-AS1 MARK3 TRIOBP RUNX1T1 ATP13A2 DSCAML1 FAF1 NAV3 MAP3K7 WNK2	1.06e-03	550	164	10	EFO_0004346, EFO_0004464
Disease	primary bacterial infectious disease (implicated_via_orthology)	GLI2 GLI3	1.08e-03	9	164	2	DOID:0050338 (implicated_via_orthology)
Disease	octanoylcarnitine measurement	COL27A1 LHX8	1.08e-03	9	164	2	EFO_0021042
Disease	cognitive function measurement	DOCK3 PCBP3 NYAP2 SZT2 TRIOBP BRD3 RUNX1T1 ZCCHC14 SLC9A2 CSE1L BBX GLI3 CRYBG1 TMEM131 MAP3K7 LMNTD1 WNK2 MAF	1.08e-03	1434	164	18	EFO_0008354
Disease	free androgen index	NYAP2 TCF12 COBLL1 FAF1 ZFHX4 PTPRG ATF1 CUX1	1.22e-03	374	164	8	EFO_0007005
Disease	Sclerocystic Ovaries	ARHGAP23 PLEKHG5 EMSY ATF1 GAB1	1.29e-03	144	164	5	C1136382
Disease	Polycystic Ovary Syndrome	ARHGAP23 PLEKHG5 EMSY ATF1 GAB1	1.29e-03	144	164	5	C0032460
Disease	sexual dimorphism measurement	GDF5-AS1 DOCK3 NYAP2 RIPK3 CDC42BPA COBLL1 ZBTB4 ATP13A2 FAF1 PTPRG GLI2 CD300LG ATF1 HERC1 WIPF2	1.34e-03	1106	164	15	EFO_0021796
Disease	Facies	CHD8 AFF4	1.34e-03	10	164	2	C0282631
Disease	Holoprosencephaly sequence	GLI2 FGFR1	1.34e-03	10	164	2	cv:C0079541
Disease	cortical surface area measurement	NYAP2 MYCBP2 ZNF423 TRIOBP CACHD1 RUNX1T1 ATP13A2 FAF1 GLI3 RP1L1 NAV3 FGFR1 MAP3K7 PCBP2 CUX1 WNK2 WWC1	1.38e-03	1345	164	17	EFO_0010736
Disease	amino acid measurement	NYAP2 TCF12 COBLL1 RUNX1T1 RYR2 PTPRG GLI2 RP1L1 NAV3 MAP3K7 WNK2	1.50e-03	678	164	11	EFO_0005134
Disease	brain-derived neurotrophic factor measurement	BRD3 CSRNP1	1.63e-03	11	164	2	EFO_0011018
Disease	nucleus accumbens volume change measurement	MUC16 WWC1	1.63e-03	11	164	2	EFO_0021493
Disease	balding measurement	TCF12 MYCBP2 ZNF423 RGS9 CASZ1 FAF1 BBX GLI2 ATF1 METTL27 CUX1 MAF	1.64e-03	792	164	12	EFO_0007825
Disease	Squamous cell carcinoma of esophagus	KRT13 XRCC1 KMT2C NOTCH3	1.98e-03	95	164	4	C0279626
Disease	Gastric Adenocarcinoma	BRD3 TRRAP BRD2	2.02e-03	45	164	3	C0278701
Disease	eosinophil percentage of granulocytes	DOCK3 KLF3 BRD3 EMSY KANSL3 TNFRSF8	2.03e-03	234	164	6	EFO_0007996
Disease	neutrophil percentage of leukocytes	NYAP2 CDC42BPA MARK3 COBLL1 KLF3 BRD3 IFI16 EMSY FAF1 TMEM131	2.27e-03	610	164	10	EFO_0007990
Disease	plasma beta-amyloid 1-42 measurement	XRCC1 PRRC1	2.30e-03	13	164	2	EFO_0005660
Disease	middle temporal gyrus volume measurement, Alzheimer's disease biomarker measurement	MYCBP2 MAP3K21	2.30e-03	13	164	2	EFO_0006514, EFO_0010316
Disease	basophil count, eosinophil count	DOCK3 KLF3 BRD3 EMSY KANSL3 TNFRSF8	2.35e-03	241	164	6	EFO_0004842, EFO_0005090
Disease	Adenoid Cystic Carcinoma	SRCAP KMT2C TLK1 SON	2.38e-03	100	164	4	C0010606
Disease	fetal genotype effect measurement, body weights and measures	PDLIM5 FGD5 TBX20	2.57e-03	49	164	3	EFO_0004324, EFO_0007959
Disease	developmental disorder of mental health (implicated_via_orthology)	TCF12 SRCAP RASAL2	2.57e-03	49	164	3	DOID:0060037 (implicated_via_orthology)
Disease	neuroimaging measurement	GDF5-AS1 CDC42BPA SZT2 MARK3 KLF3 RUNX1T1 ATP13A2 FAF1 GLI3 NAV3 MAP3K7 WNK2 WWC1 MAF	2.66e-03	1069	164	14	EFO_0004346
Disease	suicide	ATP10A RP1L1 TBX20	2.73e-03	50	164	3	EFO_0007624
Disease	polyunsaturated fatty acids to total fatty acids percentage	NYAP2 COBLL1 CD300LG	2.73e-03	50	164	3	EFO_0022303
Disease	cholesteryl esters to total lipids in IDL percentage	NYAP2 COBLL1 CD300LG	2.73e-03	50	164	3	EFO_0022247
Disease	Tourette syndrome	COL27A1 MUC16 RUNX1T1	2.73e-03	50	164	3	EFO_0004895
Disease	Leukemia, Myelocytic, Acute	NUP214 RUNX1T1 KMT2C SLX4 CUX1	2.87e-03	173	164	5	C0023467
Disease	aortic measurement	PDLIM5 RYR2 HMCN1 ATF1 FGD5 TBX20	2.88e-03	251	164	6	EFO_0020865
Disease	triglycerides to total lipids in large LDL percentage	NYAP2 COBLL1 CD300LG	2.89e-03	51	164	3	EFO_0022331
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	NYAP2 COBLL1 CD300LG	2.89e-03	51	164	3	EFO_0022302
Disease	corpus callosum posterior volume measurement	ZBTB4 ATP13A2 TMEM108	3.05e-03	52	164	3	EFO_0010298
Disease	free cholesterol to total lipids in small LDL percentage	NYAP2 COBLL1 CD300LG	3.22e-03	53	164	3	EFO_0022286
Disease	cholesteryl esters to total lipids in very large VLDL percentage	NYAP2 COBLL1 CD300LG	3.22e-03	53	164	3	EFO_0022258
Disease	asthma	DOCK3 GRB7 MUC16 KLF3 EMSY SLC9A2 BRD2 TNFRSF8 GLI3 FGFR1 GAB1	3.30e-03	751	164	11	MONDO_0004979
Disease	cholesterol to total lipids in very large VLDL percentage	NYAP2 COBLL1 CD300LG	3.40e-03	54	164	3	EFO_0022244
Disease	platelet component distribution width	NYAP2 MARK3 COBLL1 ATG14 BRD3 IRS1 ZMAT3 TLK1 HERC1 CUX1 MAF	3.43e-03	755	164	11	EFO_0007984
Disease	Synostotic Posterior Plagiocephaly	TCF12 FGFR1	3.50e-03	16	164	2	C1833340
Disease	Craniosynostosis, Type 1	TCF12 FGFR1	3.50e-03	16	164	2	C4551902
Disease	Acrocephaly	TCF12 FGFR1	3.50e-03	16	164	2	C0030044
Disease	Lobar Holoprosencephaly	GLI2 FGFR1	3.50e-03	16	164	2	C0431362
Disease	Semilobar Holoprosencephaly	GLI2 FGFR1	3.50e-03	16	164	2	C0751617
Disease	leptin measurement, type 2 diabetes mellitus	NYAP2 COBLL1	3.50e-03	16	164	2	EFO_0005000, MONDO_0005148
Disease	Trigonocephaly	TCF12 FGFR1	3.50e-03	16	164	2	C0265535
Disease	Scaphycephaly	TCF12 FGFR1	3.50e-03	16	164	2	C0265534
Disease	Synostotic Anterior Plagiocephaly	TCF12 FGFR1	3.50e-03	16	164	2	C2931150
Disease	Metopic synostosis	TCF12 FGFR1	3.50e-03	16	164	2	C1860819
Disease	cholesterol to total lipids in large HDL percentage	NYAP2 COBLL1 CD300LG	3.58e-03	55	164	3	EFO_0022234
Disease	free cholesterol to total lipids in very large HDL percentage	NYAP2 COBLL1 CD300LG	3.58e-03	55	164	3	EFO_0022288
Disease	total blood protein measurement	NYAP2 TLK1 BBX NFATC3 ARHGAP29 TMEM131 FGFR1 MAF	3.76e-03	449	164	8	EFO_0004536
Disease	essential hypertension, age at diagnosis	FGD5 TBX20 PCDH18	3.77e-03	56	164	3	EFO_0004918, MONDO_0001134
Disease	triglycerides in very large VLDL measurement	NYAP2 COBLL1 CD300LG	3.77e-03	56	164	3	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	NYAP2 COBLL1 CD300LG	3.77e-03	56	164	3	EFO_0022333
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	NYAP2 COBLL1 CD300LG	3.77e-03	56	164	3	EFO_0022316
Disease	chronotype measurement	DOCK3 MYCBP2 RUNX1T1 USP31 KANK1 PTPRG NFATC3 HECW2 NAV3 TMEM108 PRRC1 CUX1	3.94e-03	882	164	12	EFO_0008328
Disease	body fat percentage, type 2 diabetes mellitus	NYAP2 COBLL1	3.95e-03	17	164	2	EFO_0007800, MONDO_0005148
Disease	Brachycephaly	TCF12 FGFR1	3.95e-03	17	164	2	C0221356
Disease	bacteriemia	DOCK3 PTPRG	3.95e-03	17	164	2	EFO_0003033
Disease	free cholesterol to total lipids in medium VLDL percentage	NYAP2 COBLL1 CD300LG	3.96e-03	57	164	3	EFO_0022284
Disease	low density lipoprotein particle size measurement	NYAP2 COBLL1 CD300LG	4.16e-03	58	164	3	EFO_0008593
Disease	basal cell carcinoma	CCDC88B KANK1 ULBP2 RAET1L CUX1	4.19e-03	189	164	5	EFO_0004193
Disease	triglycerides in VLDL measurement	NYAP2 COBLL1 CD300LG	4.36e-03	59	164	3	EFO_0022326
Disease	triglycerides to total lipids in small LDL percentage	NYAP2 COBLL1 CD300LG	4.36e-03	59	164	3	EFO_0022337
Disease	prostate carcinoma, type 2 diabetes mellitus	NYAP2 EMSY ZNF512	4.36e-03	59	164	3	EFO_0001663, MONDO_0005148
Disease	insulin resistance	PCBP3 NYAP2 COBLL1	4.36e-03	59	164	3	EFO_0002614
Disease	cholesteryl esters to total lipids in large HDL percentage	NYAP2 COBLL1 CD300LG	4.36e-03	59	164	3	EFO_0022248
Disease	BMI-adjusted fasting blood insulin measurement	NYAP2 COBLL1	4.43e-03	18	164	2	EFO_0008037
Disease	immature platelet measurement	DOCK3 BRD3 ZMAT3 TLK1	4.45e-03	119	164	4	EFO_0803541
Disease	triglycerides to total lipids in large HDL percentage	NYAP2 COBLL1 CD300LG	4.57e-03	60	164	3	EFO_0022330
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	NYAP2 COBLL1 CD300LG	4.57e-03	60	164	3	EFO_0021898
Disease	cholesterol to total lipids in IDL percentage	NYAP2 COBLL1 CD300LG	4.57e-03	60	164	3	EFO_0022233
Disease	cholesterol to total lipids in medium HDL percentage	NYAP2 COBLL1 CD300LG	4.57e-03	60	164	3	EFO_0022237
Disease	free cholesterol to total lipids in medium HDL percentage	NYAP2 COBLL1 CD300LG	4.57e-03	60	164	3	EFO_0022282
Disease	triglycerides in small VLDL measurement	NYAP2 COBLL1 CD300LG	4.79e-03	61	164	3	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	NYAP2 COBLL1 CD300LG	4.79e-03	61	164	3	EFO_0022274

Protein segments in the cluster

Peptide	Gene	Start	Entry
KTGVPTASPASSADM	PTPRG	456	P23470
TASPASSADMAPISS	PTPRG	461	P23470
MSTATTVAPAGIPAT	BRD3	1	Q15059
APPKRSFSSMSDITG	CARD10	541	Q9BWT7
SPVPTPRSSSAASMA	CHD8	2211	Q9HCK8
GETRSSTPEMPAVSA	BBX	881	Q8WY36
TGSPSPAPMRRAQSS	CCDC88B	1366	A6NC98
KPFPRSNSTSSMSSG	ABL2	776	P42684
ASPPIASSSAGGMIS	ATG14	461	Q6ZNE5
AGSTPEAATSSMLPT	CASZ1	211	Q86V15
GMAPSPSQSESAGSV	CUX1	531	P39880
ESPTIMLSAGSFSSP	CACHD1	651	Q5VU97
SAAPSASAPAMTTVE	SPECC1L	81	Q69YQ0
SSMSPLPSQSRAFGV	AHDC1	1321	Q5TGY3
SNMPSTPASTISARE	CEP170B	1366	Q9Y4F5
TPTDGPSFTVMRQSS	COBLL1	1056	Q53SF7
MFDTTPHSGRSTPSS	GRAMD1A	1	Q96CP6
SMRFSSLCPPSTSTA	ATP10A	951	O60312
SETPVDLASSMPSSR	AFF4	586	Q9UHB7
MPGVANSGPSTSSRE	ANKRD42	1	Q8N9B4
NASRSGPPPSSGMSS	RBM12	101	Q9NTZ6
STASVGTAPPNMGAS	RBM12	151	Q9NTZ6
SAPGSSMPIRIESSS	HSPG2	2721	P98160
MAPRGPSVTESSEAS	RGS9	546	O75916
LPLSSSMTPASSSSR	IRF2	311	P14316
RSSPSSSPTLERGQM	PCDH18	776	Q9HCL0
MGASPKLRSSFPTDT	HECW2	441	Q9P2P5
PRDGTSSALTPQMTA	MUC16	1121	Q8WXI7
PGGTRQSLATMSSVS	MUC16	3301	Q8WXI7
VASSRLSNSPPMTIS	MUC16	4661	Q8WXI7
SSPDATPVMATSPRT	MUC16	11711	Q8WXI7
TSRTPASLSGPMTAS	MUC16	13461	Q8WXI7
PSPFTGSSTRNMESG	OR6K3	6	Q8NGY3
SMTNSTAASRPPVTL	PCBP1	86	Q15365
SSHRRASPGLSMPSS	KLF3	86	P57682
PSLSMISATRGLSPT	GLI3	211	P10071
PSALSSSAGNIMPTT	KMT2C	801	Q8NEZ4
AGGSLSSTPMSTPCS	MAF	51	O75444
GTPKSMTSLSPRSSL	WWC1	526	Q8IX03
SRGTSGPPLTMATVS	SPN	161	P16150
VSSSVTPNSGAGSPM	RUNX1T1	566	Q06455
TSVPPSMDAGRSSSV	CSRNP1	481	Q96S65
PTAGMSPSRSNTIST	GAB1	376	Q13480
MVSLTSPSAPASSRT	PPFIA3	901	O75145
MSSPAVARTSPGGSR	LONRF1	1	Q17RB8
SRPSGSSSSSGVLMV	CSNK1G1	26	Q9HCP0
GRAGLSTSPSAMAST	HERC1	3231	Q15751
MIGFPSSAGSVSPRS	KRT13	416	P13646
SSRVSPGTRPTAMGS	ARNTL2	26	Q8WYA1
DMTARPTGPQVTSSA	PCSK4	581	Q6UW60
MSTPGVNSSASLSPD	PTGER4	1	P35408
SSSVMPSPSTTLARQ	NAV3	1271	Q8IVL0
VSMSFPLSSPRFSGS	FGD5	1316	Q6ZNL6
LPPMSSFHRGSTSSS	TCF12	291	Q99081
RSSSPSVRMITTSGP	MAP3K7	456	O43318
GLTPLSTTAPSMFSA	MRTFB	1061	Q9ULH7
PSPATATGAMATTTG	NOTCH3	2271	Q9UM47
PSLPHSASLRSTGSM	RASAL2	886	Q9UJF2
APAAPTTSSMGSSIR	KANK1	226	Q14678
LLSSATTPSLPMSAG	NUP214	1476	P35658
TTPSLPMSAGRSTEE	NUP214	1481	P35658
APLSPSSSPRSMASG	LHX8	51	Q68G74
ATTLPLSSSNSSGMP	LMNTD1	31	Q8N9Z9
SPTLSMISAARGLSP	GLI2	136	P10070
STPVSSRSPAPSSGM	TEPSIN	396	Q96N21
ASTRSMPESLDSPTS	PDLIM5	321	Q96HC4
SLPRDSSLSQMGSPA	NYAP2	221	Q9P242
SRLPSSGEAAATPTM	PACS2	786	Q86VP3
MSRPASVDGSPVSPS	IRS1	336	P35568
PGPTSSATNVSMVVS	NBPF1	261	Q3BBV0
SLPMPASGTSLSAAI	GRB7	411	Q14451
MGQSSGLDASPPAST	PCBP3	281	P57721
SSTSMACITDGTPAP	HMCN1	3451	Q96RW7
SLPRMASSPALSTCT	METTL27	221	Q8N6F8
SMTNSTAASRPPVTL	PCBP2	86	Q15366
PGPTSSATNVSMVVS	NBPF3	46	Q9H094
KLPRTPSSGTMSSAD	ARHGAP29	566	Q52LW3
MSADSSPLVGSTPTG	ATP13A2	1	Q9NQ11
SPPSKSRSMSNTTEG	FCAMR	266	Q8WWV6
LLAAGAPMSSSASVP	HECTD1	1521	Q9ULT8
APMSSSASVPNLSSR	HECTD1	1526	Q9ULT8
SSVSQGRPGFATMPS	BICRAL	516	Q6AI39
VTSMSGPSRFPAVSS	BICRAL	531	Q6AI39
APSQMITSAPSSARG	DOCK3	1751	Q8IZD9
SRPSSDSCSVPMTGA	CCDC34	26	Q96HJ3
PSSSQAGSMSSAGPR	CRY2	536	Q49AN0
SMSLPAAAPTTSVFS	EBF4	526	Q9BQW3
PSRLSSSGTPMLAGV	FGFR1	446	P11362
TSMSTPSEPGICRFT	DSCAML1	1856	Q8TD84
SSGCMLSPPLGRTTT	CCDC191	486	Q8NCU4
SSAPSSPSFSRALMS	GDF5-AS1	181	Q5U4N7
PSPGSARSMGSHTTR	CDC42EP4	291	Q9H3Q1
AGTSSERSKSSVMPP	CEP350	1271	Q5VT06
PQPMRSSTSGATSFG	CEP350	2416	Q5VT06
MPVRSTSAGSTPTHC	DTNB	546	O60941
TMVPPTSGTSTPRTA	COL27A1	506	Q8IZC6
TAMGRSPSPKTSLSA	IFI16	161	Q16666
TVPSSNTASGGMTRR	MARK3	491	P27448
TSAGPDTIMPSSSSR	ITIH6	626	Q6UXX5
TMSLLNSSRPTPEGS	ITIH6	966	Q6UXX5
RITTLSPMGSGAAPS	KANSL3	871	Q9P2N6
SPSIGRMAATPGAAT	EMSY	516	Q7Z589
PTSSSSSAFRPVMPS	FAF1	76	Q9UNN5
SQGSRTPLMAESSPT	CRYBG1	636	Q9Y4K1
SVGLASPAMRGSTPL	RYR2	2226	Q92736
MRSSNSASASAGPPG	HOXA4	281	Q00056
PSSIAASMVPSAAAA	PITX3	191	O75364
RAMSTTSISSPQPGK	DBNL	266	Q9UJU6
MAPVSGSRSPDREAS	NKAP	1	Q8N5F7
SPPTSPSSASRGMLS	FAM114A1	196	Q8IWE2
MASSSVPPATVSAAT	PIP4K2C	1	Q8TBX8
AMAPSGLTAAPTSLG	MKNK1	176	Q9BUB5
SNSAPSGGSTPLTRM	MUC17	266	Q685J3
TSTPGERSTPLTSMP	MUC17	1211	Q685J3
SMPTSTPGERSTPLT	MUC17	2681	Q685J3
MRISTPSDGSTPLTS	MUC17	2741	Q685J3
SQASSSPPIADGTSM	MUC17	3316	Q685J3
TMSTAPSTPRTTSRG	MUC17	4006	Q685J3
SAPTTPRGVAMLTSD	GRIN3B	721	O60391
APSSGVVCTPIMSTS	RTL9	171	Q8NET4
ASGTMSTPLRRPSAC	RTL9	906	Q8NET4
AAPPAAVSASGTVTM	TAF4B	11	Q92750
ASGPRSPLDMVSSRS	SZT2	2131	Q5T011
SSSLTSAPAPMLSAV	MRPL43	186	Q8N983
LPGTPAMATTAASSG	SYT15	41	Q9BQS2
STVPASLDSSRSEPM	SYNDIG1	56	Q9H7V2
RRTMSDGNPTPTGAT	MAP3K21	891	Q5TCX8
PGPTSSATNVSMVVS	NBPF8	226	Q3BBV2
PGPTSSATNVSMVVS	NBPF9	261	P0DPF3
PGPTSSATNVSMVVS	NBPF10	261	Q6P3W6
PGPTSSATNVSMVVS	NBPF11	261	Q86T75
PGPTSSATNVSMVVS	NBPF12	261	Q5TAG4
TAMSGRGSVLASLSP	FAM90A12P	171	A8MX19
SWMSAAPTSLGPRTT	SIGLEC6	181	O43699
SSRPAMIGSLTDGST	MYCBP2	3751	O75592
MDSDASLVSSRPSSP	OLIG2	1	Q13516
AMSSTPVPLAATSSF	PRRC1	26	Q96M27
VMAPSSTPGTSLASA	SRCAP	1631	Q6ZRS2
RPEPGRSMSASSGLS	CDC42BPA	1621	Q5VT25
TQASSMTPHSGPRST	TRIOBP	241	Q9H2D6
MTPHSGPRSTTSQAS	TRIOBP	246	Q9H2D6
TGPLSTSSPSRRMNE	SLX4	1446	Q8IY92
MSSSSPPAGAASAAI	PPP2R5A	1	Q15172
STAMPPGLAKSSSES	BRD2	466	P25440
SGVSAAVTSMSVPTP	ATF1	86	P18846
AGSSRPPMQLDSTSA	CD300LG	211	Q6UXG3
MSTEGPSLASSPAIS	C10orf105	1	Q8TEF2
TPRSSGGTKMPATDS	C11orf24	361	Q96F05
IASMPRSPSSAGSPR	RNF223	21	E7ERA6
TSLGLVMPASAGPRS	INPP5J	136	Q15735
AASSPTIMRKSSGSP	PLEKHG5	731	O94827
MSVQSSSGSLEGPPS	TLK1	1	Q9UKI8
MLGFPTSATSSPALS	ZFHX4	3086	Q86UP3
PLSSTSQMGSTLPSG	THRAP3	276	Q9Y2W1
STACPGRVPSMVSTS	CSE1L	936	P55060
EPSTAASGPASAATM	REPS2	581	Q8NFH8
RSSKPSMSLAPSGSS	SRRM5	6	B3KS81
TSTFRNQMPSPTSTG	RIPK3	401	Q9Y572
HRSRASAMSSPSSPG	RP1L1	641	Q8IWN7
SAMSSPSSPGLGRVA	RP1L1	646	Q8IWN7
RAMGTSSSPPSPASV	SLC9A2	41	Q9UBY0
SSAMNSAPVLGTSPS	ARHGAP23	571	Q9P227
PLPTAMTSGSKSRNA	TMEM131	1506	Q92545
VAGSAPMPGTDSSSR	UBL7	196	Q96S82
PVSPATSSASTMPVR	TNFRSF8	181	P28908
SPATAAGPAMATTTE	ZBTB4	541	Q9P1Z0
SSGTASSPSPATRMH	NFATC3	956	Q12968
MSRGPSSAVLPSALG	PPP1R3D	1	O95685
EPSAGAPLAMSSGTT	RAET1L	206	Q5VY80
NASPTMAPSTAVTAR	TTLL3	471	Q9Y4R7
PRSSRPSSSQSTEGM	PKD2	941	Q13563
LITSGGAAAAMSSPP	TMEM174	166	Q8WUU8
SSSMSPTVSFGPRTK	ZCCHC14	581	Q8WYQ9
SSFMSPSESRSGSNP	XRCC1	91	P18887
SPSPPMSVATRSTGT	ZMAT3	16	Q9HA38
PTMASPRGSGSSTSL	PLEKHG2	41	Q9H7P9
SRLGMPLTPSAIASS	TBX20	391	Q9UMR3
TSTSPTRSMAPGAVH	TNFRSF1B	201	P20333
SPDPVLGSVASMSSA	ZNF423	356	Q2M1K9
SPSSPSSARSVGSFM	USP31	51	Q70CQ4
LPDLSRPNTTSSTGM	WIPF2	156	Q8TF74
STMPEPASGTASQAG	WNK2	1441	Q9Y3S1
EPSAGAPLAMSSGTT	ULBP2	206	Q9BZM5
MSSRLGAVPATSGPT	ZNF512	1	Q96ME7
QTAVRPGSPSTSTMR	TRRAP	1621	Q9Y4A5
MATADTPAPASSGLS	ZFC3H1	1	O60293
SAASPVVSSMPERAS	SON	1766	P18583
MSESSGSALQPGRPS	TMC7	1	Q7Z402
SPSQVAMASFSSAGP	ZNF541	771	Q9H0D2
SSLSTGPAPAAMATT	TMEM108	111	Q6UXF1
QGMFAPRSSTSIAPS	USP54	16	Q70EL1
PITSASMETTALPGS	MUC12	256	Q9UKN1
SPDAMATTVLPAGST	MUC12	586	Q9UKN1